Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3027544	ex-tbvrvi	— (—)	4072	15897	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other diseases of pleura

882

1831

4.31

318.03

4.1

3.5

—

Asthma

1237

308

21.19

307.65

4.3

2.8

—

COPD, hospital admissions

901

1769

4.42

307.65

4.0

3.6

—

Undetermined asthma

232

26.63

307.65

4.7

2.7

—

Influenza and pneumonia

1844

1525

7.63

307.65

4.3

3.6

—

Other interstitial pulmonary diseases

511

711

7.68

307.65

3.5

3.6

—

Non-allergic asthma (mode)

402

130

31.84

307.65

4.9

2.6

—

Chronic lower respiratory diseases

1770

1782

5.32

307.65

4.4

3.4

—

Other respiratory diseases principally affecting the interstitium

557

831

7.11

307.65

3.5

3.6

—

Other chronic obstructive pulmonary disease

898

1151

6.60

307.65

4.0

3.0

—

Asthma-related infections

1256

1961

6.43

307.65

4.5

3.6

—

Interstitial lung disease

511

714

7.65

307.65

3.5

3.6

—

Asthma (only as main-diagnosis), excluding more controls

1166

271

24.37

307.65

4.4

2.8

—

Asthma/COPD (KELA code 203)

1461

1780

5.59

307.65

4.5

3.4

—

Abnormal findings on diagnostic imaging of lung

1307

1856

6.97

307.65

4.3

3.4

—

Bacterial pneumonia (organism specified)

1051

1433

6.88

307.65

4.4

3.3

—

Asthma, excluding more controls

1171

271

22.69

307.65

4.3

2.8

—

Undetermined asthma, excluding more controls

232

29.23

307.65

4.7

2.8

—

COPD, hospital admission 2, with asthma infections

779

1258

5.54

307.65

4.1

3.5

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

723

1080

6.00

307.65

4.2

3.5

—

845

1327

6.49

307.65

4.7

3.6

—

Asthma and opportunity respiratory infection

397

154

32.64

307.65

7.0

3.7

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1687

1096

9.23

307.65

4.5

3.5

—

Other pulmonary diagnosis

804

308

13.26

307.65

3.8

2.8

—

Bronchiectasis

571

192

35.70

307.65

6.4

2.6

—

Asthma, hospital admission 2, infections

1256

1961

6.43

307.65

4.5

3.6

—

Cough

772

1062

6.97

307.65

4.4

3.7

—

1687

1096

9.23

307.65

4.5

3.5

—

Oral corticosteroids

1601

2021

4.73

307.65

4.1

3.6

—

COPD differential diagnosis

793

311

12.95

307.65

3.9

2.8

—

COPD (mode)

646

206

25.39

307.65

3.9

2.7

—

COPD/asthma related infections

1163

1096

5.39

307.65

4.0

3.5

—

Asthma, unspecified (mode)

876

296

21.88

307.65

4.0

2.7

—

Later onset COPD, excluding more controls

426

144

23.46

307.65

3.7

2.7

—

Early onset COPD, excluding more controls

437

150

30.34

307.65

4.4

2.6

—

Haemorrhage from respiratory passages

732

967

6.92

307.65

4.3

3.4

—

Asthma (mode)

1068

311

18.40

307.65

4.1

2.8

—

Asthma, including avohilmo

1574

2332

3.77

307.65

4.2

3.7

—

COPD

952

1182

6.77

307.65

4.1

3.0

—

ILD, hospital admissions

507

697

7.78

307.65

3.5

3.6

—

ILD, hospital admissions 1, main diag only

462

621

7.98

307.65

3.4

3.7

—

Inflammatory bowel disease treatment related agents

1545

2044

4.26

307.65

4.1

3.7

—

ILD, hospital admission 2, with pulmonary infections

410

222

20.22

307.65

3.6

3.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

1512

1794

4.76

307.65

4.1

3.7

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

436

188

17.51

307.65

3.6

3.2

—

Pneumonia, organism unspecified

1826

1488

8.65

307.65

4.3

3.6

—

First line medication for Crohn's disease

1318

1759

4.08

307.65

4.0

3.8

—

Asthma, hospital admissions 3, pneumonia

1043

1331

8.18

307.65

4.8

3.4

—

ILD, hospital admissions 3, with pneumonia sepsis

364

214

18.71

307.65

3.5

3.1

—

Asthma (diagnoses ohter than nonallergic)

1449

2536

4.71

307.65

4.3

3.6

—

Excluding asthma or asthma-COPD overlap

794

308

13.09

307.65

3.9

2.8

—

Non-allergic asthma (mode), excluding more controls

402

117

35.38

307.65

4.9

2.8

—

ILD medications

1456

1805

4.41

307.65

4.1

3.7

—

Interstitial lung disease endpoints

511

714

7.65

307.65

3.5

3.6

—

Bacterial pneumonia, not elsewhere classified

941

852

10.08

307.65

4.5

3.4

—

Other chronic obstructive pulmonary disease, including avohilmo

1000

2017

4.18

307.65

4.1

3.6

—

All pneumoniae

1883

1570

7.99

307.65

4.2

3.6

—

COPD, early/later onset

903

1772

4.41

307.65

4.0

3.5

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1879

1606

7.99

307.65

4.3

3.6

—

Asthma, hospital admissions , main diagnosis only

1316

2597

4.49

307.65

4.4

3.7

—

Respiratory insufficiency

217

38.11

307.65

4.3

2.6

—

Bacterial pneumoniae

974

905

9.82

307.65

4.5

3.4

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1434

2229

5.77

307.65

4.3

3.5

—

Lung cancer and mesothelioma

424

136

27.57

307.65

3.3

2.8

—

ILD differential diagnosis

791

311

12.92

307.65

3.9

2.8

—

COPD/asthma/ILD related infections

1163

1096

5.39

307.65

4.0

3.5

—

Asthma (only as main-diagnosis)

1211

308

22.52

307.65

4.4

2.8

—

Pneumonias (Asthma/COPD co-morbidities)

1915

1541

8.33

307.65

4.4

3.5

—

Asthma-related pneumonia

1041

1328

8.18

307.65

4.8

3.4

—

Asthma-related pneumonia or sepsis

1043

1331

8.18

307.65

4.8

3.4

—

Asthma, unspecified (mode), excluding more controls

837

260

23.59

307.65

4.0

2.7

—

Other acute lower respiratory infections

881

2103

4.07

305.64

4.8

3.6

—

Diseases of the respiratory system

573

346

8.39

302.65

4.0

3.8

—

Allergic asthma (mode), excluding more controls

240

125

19.04

300.51

4.2

2.8

—

Abnormalities of breathing

975

1364

4.14

290.69

3.8

—

Allergic asthma (mode)

240

135

17.63

289.97

4.2

2.8

—

Dyspnoea

1202

2634

3.34

289.53

3.9

3.8

—

Bacterial infection, other or unspecified, including avohilmo

927

1988

3.90

289.44

3.6

3.4

—

Acute bronchitis

725

1640

4.44

283.74

4.6

3.5

—

Other bacterial diseases

1208

2437

3.33

281.55

4.5

3.6

—

Bacterial infection, other or unspecified

867

1916

3.90

273.05

3.5

3.4

—

COPD, hospital admissions 1, only main diagnosis

718

1417

4.50

271.79

4.0

3.5

—

1279

1969

3.33

271.69

4.4

3.4

—

COPD related to multimorbidity

764

1561

4.26

269.10

4.1

3.5

—

Other bacterial diseases, including avohilmo

1200

2345

3.23

262.68

4.5

3.6

—

Bacterial Sepsis

817

1795

3.85

250.85

3.7

—

ILD medications: immunosuppressive drugs

710

1605

4.06

243.45

3.9

3.7

—

Early onset COPD

437

811

5.58

223.76

4.4

3.6

—

Implicit bacterial Sepsis

726

1666

3.82

223.35

3.8

3.7

—

Infections, IBD-co-morbidities

315

234

9.76

222.84

7.3

3.5

—

Implicit bacterial Sepsis, including avohilmo

764

1762

3.68

221.26

3.9

3.7

—

Bronchitis

1256

2673

2.85

220.36

4.5

3.6

—

Obesity related asthma

498

1061

4.80

216.59

4.2

3.4

—

All influenza

361

577

6.39

214.98

4.7

3.4

—

Chronic sinusitis

597

1517

4.00

205.89

5.4

3.6

—

159

21.60

203.35

6.6

3.8

—

Viral pneumonia

248

280

9.18

201.14

4.0

3.4

—

Symptoms and signs involving the circulatory and respiratory systems

906

1365

3.36

194.48

4.1

3.8

—

Codes for special purposes

731

2221

3.32

190.13

4.2

3.7

—

Provisional assignment of new diseases of uncertain etiology

730

2217

3.32

190.04

4.2

3.7

—

Infection due to other mycobacteria, including avohilmo

133

28.75

189.96

13.5

3.6

—

Lung transplantation

108

64.21

186.09

5.4

3.5

—

Infection due to other mycobacteria

130

29.01

185.59

13.8

3.6

—

Other respiratory disorders and diseases

433

953

4.70

181.90

4.1

3.5

—

Other diseases of the respiratory system

433

953

4.70

181.90

4.1

3.5

—

Lung transplant status

106

62.57

181.71

5.4

3.5

—

Asthma and allergy, excluding more controls

138

21.02

181.68

4.3

2.8

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1096

2770

2.69

180.03

3.8

—

Emphysema

206

212

10.30

179.96

4.5

2.9

—

Tramadol

884

1730

3.11

179.89

3.7

3.9

—

Fever of other and unknown origin

696

1829

3.34

177.39

3.8

3.9

—

Implicit Sepsis

930

2405

2.88

177.21

3.8

—

Asthma and allergy

138

19.81

177.05

4.3

2.8

—

COPD-related respiratory insufficiency

303

516

6.17

170.78

4.3

3.7

—

Chronic rhinitis, nasopharyngitis and pharyngitis

448

1078

4.24

166.90

4.2

3.7

—

Suppurative and necrotic conditions of lower respiratory tract

203

239

9.21

160.91

4.3

3.7

—

Atypical mycobacterium lung infection

105

35.71

159.93

14.3

3.1

—

Covid-19 confirmed case

555

1630

3.47

154.92

4.1

3.7

—

Pain in throat and chest

726

1354

3.20

154.63

4.1

3.8

—

Bleeding

979

2649

2.62

154.07

4.0

3.7

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

454

930

4.13

152.83

3.4

3.7

—

Implicit Sepsis, including avohilmo

918

2475

2.68

151.55

3.8

3.9

—

Idiopathic pulmonary fibrosis

236

362

6.95

148.13

3.7

3.6

—

Implicit viral Sepsis, including avohilmo

464

1256

3.76

146.42

4.2

3.6

—

Malignant neoplasm of bronchus and lung, including Hilmo

417

848

4.23

145.05

3.3

3.7

—

Respiratory tuberculosis, confirmed, including avohilmo

118

19.46

144.62

13.1

3.9

—

Respiratory tuberculosis, confirmed

115

19.80

142.14

13.3

3.8

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

115

18.06

136.13

13.3

3.8

—

Certain infectious and parasitic diseases

842

1535

2.77

133.11

4.3

3.2

—

Continuous positive airway pressure

296

486

5.20

132.57

3.7

3.8

—

Later onset COPD

480

1125

3.51

128.12

3.7

3.5

—

Malignant neoplasm of respiratory system and intrathoracic organs

397

849

3.99

127.98

3.3

3.7

—

Non-small cell lung cancer, including Hilmo

307

640

4.65

125.03

3.2

3.9

—

Tuberculosis, IBD comorbidity

201

311

6.84

124.94

9.4

3.2

—

Tuberculosis

189

279

7.20

122.96

9.7

3.5

—

Tuberculosis, wide, including avohilmo

206

339

6.42

120.52

9.4

3.5

—

Malignant neoplasm of bronchus and lung

356

752

4.07

118.36

3.1

3.8

—

Tuberculosis, wide

202

333

6.40

117.97

9.4

3.5

—

Abscess of lung

19.02

117.31

4.3

4.2

—

Malaise and fatigue

598

1651

2.88

116.48

3.6

3.7

—

Condition for Implicit Sepsis (Organ dysfunction codes)

867

2499

2.42

116.45

3.9

—

Pneumonia due to other infectious organisms, not elsewhere classified

101

16.19

116.34

3.8

3.2

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

869

2439

2.42

116.02

3.9

—

Pleural effusion

290

674

4.44

113.88

3.6

3.4

—

Viral Sepsis

327

831

4.03

113.59

4.2

3.6

—

Implicit viral Sepsis

326

830

4.02

112.96

4.2

3.6

—

Heart failure, not strict

798

2174

2.49

112.62

3.6

3.8

—

Persons encountering health services for specific procedures and health care

982

2541

2.30

112.44

4.2

3.8

—

Respiratory tuberculosis

170

247

7.34

112.35

10.3

3.6

—

Respiratory tuberculosis, confirmed and not-confirmed

170

247

7.34

112.35

10.3

3.6

—

L04AA Selective immunosuppressants

315

797

4.04

110.08

4.2

3.7

—

Suggestive for eosinophilic asthma

179

287

6.48

107.05

4.7

3.6

—

Oxycodone

487

1392

3.03

105.75

3.7

3.8

—

Septicaemia

515

1641

2.90

104.98

3.5

3.4

—

Certain infectious and parasitic diseases, including avohilmo

581

982

2.99

104.76

4.1

3.1

—

Implicit fungal Sepsis, including avohilmo

173

276

6.57

104.24

4.2

3.9

—

Transplanted organ and tissue status

202

376

5.59

103.52

4.3

3.8

—

Examination and observation for other reasons

598

1208

2.82

101.71

3.9

3.7

—

L04AD Calcineurin inhibitors

198

369

5.56

101.23

4.2

3.9

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

235

189

6.28

101.11

4.3

3.5

—

Unspecified acute lower respiratory infection

248

560

4.54

100.89

4.6

3.4

—

Care involving use of rehabilitation procedures

654

2365

2.51

100.67

4.3

3.8

—

Certain disorders involving the immune mechanism

284

713

4.08

100.47

4.5

3.7

—

ILD-related respiratory insufficiency

126

149

9.26

99.83

3.4

4.3

—

Speech therapy

368

1105

3.40

99.81

4.0

3.6

—

Explicit Sepsis, including avohilmo

538

1792

2.76

99.72

3.5

3.7

—

Diseases of oesophagus, stomach and duodenum

987

2713

2.16

98.18

3.9

—

Heart failure,strict

624

1701

2.59

96.24

3.5

3.8

—

Erysipelas, including avohilmo

711

2203

2.41

96.23

3.7

3.5

—

Acute sinusitis

506

1667

2.79

96.18

4.9

3.7

—

Explicit Sepsis

524

1771

2.73

95.44

3.5

3.7

—

All kidney diseases

896

2796

2.16

91.95

3.8

3.9

—

Renal tubulo-interstitial diseases

840

2842

2.18

90.05

3.6

3.9

—

Codeine

768

1788

2.34

89.35

3.7

4.0

—

All influenza (not pneumonia)

165

293

5.74

88.47

5.1

3.4

—

Aspergillosis

21.60

86.73

6.5

4.3

—

Aspergillosis, including avohilmo

20.77

86.51

6.5

4.2

—

Other diseases of upper respiratory tract

989

2499

2.08

85.86

4.2

3.7

—

Heart failure, strict

687

2064

2.34

85.40

3.5

3.7

—

Immunodeficiencies

116

150

8.16

84.81

5.2

3.7

—

Non-small cell lung cancer

209

468

4.56

84.66

3.2

3.6

—

General symptoms and signs

867

2002

2.18

84.44

4.0

—

Immunodeficiency with predominantly antibody defects

11.50

83.07

4.4

4.0

—

Other septicaemia, including avohilmo

445

1545

2.74

82.23

3.6

3.4

—

Anaemias

184

210

5.67

81.80

4.0

4.1

—

Other septicaemia

434

1512

2.74

80.49

3.6

3.4

—

All-cause Heart Failure

667

2035

2.31

80.26

3.5

3.7

—

Diagnoses used for exclusion with ILD

344

1143

3.07

78.87

3.6

3.5

—

Exposure to unspecified factor

919

3123

2.01

78.87

4.0

3.9

—

Dental caries

298

849

3.36

78.81

4.6

3.8

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

989

2642

2.00

78.49

4.1

3.8

—

Voice disturbances

333

1091

3.11

78.20

3.9

3.7

—

Pain in limb

746

2183

2.19

77.89

3.7

3.9

—

Pneumocystosis

11.38

77.35

3.5

4.0

—

Pneumocystosis, including avohilmo

11.38

77.35

3.5

4.0

—

Opioids

764

1804

2.20

76.62

3.6

4.1

—

Acute upper respiratory infections

937

2830

2.00

76.24

4.4

3.7

—

Implicit fungal Sepsis

108

146

7.85

76.13

4.4

—

Fungal Sepsis

112

158

7.50

75.98

4.3

—

Any death

671

2135

2.22

74.20

3.6

3.8

—

Protozoal diseases

118

8.79

73.59

3.4

4.8

—

Acute upper respiratory infections of multiple and unspecified sites

680

2286

2.18

73.31

4.4

3.7

—

Pain, not elsewhere classified

299

955

3.17

73.19

3.8

3.9

—

Protozoal diseases, including avohilmo

119

8.68

73.03

3.4

4.7

—

Dysphagia

329

1121

2.98

72.15

4.4

3.8

—

Simple and mucopurulent chronic bronchitis

112

8.69

71.99

4.6

2.6

—

Pyothorax

117

186

6.67

71.06

4.1

3.8

—

Aplastic and other anaemias

550

2203

2.31

70.78

3.5

3.6

—

Candidiasis, including avohilmo

331

1145

2.93

70.53

4.4

3.9

—

Codeine or tramadol medication

963

2723

1.93

69.77

3.7

3.9

—

Viral pneumonia (unknown virus, not influenza)

121

203

6.17

69.23

3.2

3.7

—

Allergic bronchopulmonary aspergillosis (ABPA)

45.28

69.22

7.3

2.8

—

Erysipelas

542

2044

2.31

68.85

3.6

3.5

—

Symptoms and signs involving speech and voice

379

1433

2.68

68.25

3.7

—

Other heart diseases

359

806

2.92

68.21

3.6

4.0

—

Caries of dentine

259

761

3.33

67.97

4.7

3.8

—

Persons encountering health services in other circumstances, wide

983

2661

1.91

67.90

4.0

3.8

—

Pulmonary heart disease, diseases of pulmonary circulation

396

1540

2.61

67.40

3.8

3.6

—

Mycoses, including avohilmo

812

3159

1.97

67.14

4.1

3.9

—

Any reimbursement code in KELA

353

583

3.05

66.36

4.6

4.7

—

Other anaemias

511

2106

2.30

65.21

3.5

3.6

—

Other and unspecified immunodeficiencies with predominantly antibody defects

16.51

64.99

4.9

4.1

—

Other and unspecified anaemias

506

2091

2.30

64.65

3.5

3.6

—

Other soft tissue disorders, not elsewhere classified

777

2213

2.01

63.64

3.7

4.0

—

Polyarthropathies

619

1859

2.15

62.63

3.8

3.9

—

Medical observation and evaluation for suspected diseases and conditions

551

1225

2.31

62.00

4.0

3.7

—

Second line medication for Crohn's disease

528

2414

2.20

61.99

3.7

3.9

—

Renal failure

553

2172

2.19

61.96

3.5

3.6

—

L04AX Other immunosuppressants

520

2371

2.21

61.56

3.7

3.9

—

Intestinal infectious diseases, including avohilmo, including avohilmo

976

2977

1.84

61.11

3.9

—

Gastro-oesophageal reflux disease

621

2539

2.08

60.84

3.9

3.8

—

All chronic kidney diseases

556

2057

2.17

60.38

3.9

3.8

—

Other medical care

502

1884

2.26

60.34

3.7

—

Other pleural conditions

167

416

4.13

60.05

3.5

—

Metabolic disorders

788

2456

1.94

59.01

4.1

3.9

—

Any gastric operation

546

1213

2.27

58.63

4.2

3.8

—

GASTRO-related operations

546

1213

2.27

58.63

4.2

3.8

—

Viral hepatitis, IBD co-morbidity

9.42

58.47

3.6

4.0

—

Diaphragmatic hernia

405

1712

2.40

57.70

3.7

—

Other heart diseases, wide

684

2069

2.01

57.24

3.5

4.1

—

Diverticular disease of intestine

683

2134

2.01

57.07

3.6

3.8

—

Osteopathies and chondropathies

548

2400

2.10

56.34

3.9

3.8

—

Heart failure and antihypertensive medication

272

582

3.08

56.32

3.4

4.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

453

1954

2.25

55.91

3.8

3.7

—

Autoimmune diseases related-to ILD

678

2933

1.94

55.00

3.7

4.0

—

Osteoporosis

326

1164

2.61

54.74

4.0

3.7

—

Covid-19 suspected case

213

664

3.25

54.49

4.5

3.8

—

Unspecified privation

156

399

4.01

54.08

4.5

3.9

—

Intestinal infectious diseases

791

3241

1.82

51.87

3.9

—

ILD medications: pirfenidone

13.92

50.54

3.4

3.2

—

Chronic gastritis

311

1245

2.53

50.02

3.7

3.6

—

Non-small cell lung cancer, adenocarcinoma

120

271

4.59

49.27

3.1

3.8

—

Constipation

777

2916

1.82

49.26

3.9

3.8

—

ILD medications: azathioprine

134

328

4.14

49.16

4.3

3.4

—

Autoimmune diseases excluding thyroid diseases

856

2610

1.79

49.00

3.9

4.0

—

Heart failure and bmi 25plus

332

893

2.51

47.75

3.2

3.6

—

Autoimmune diseases excluding thyroid diseases, strict definition

828

2534

1.79

47.45

3.9

4.0

—

Childhood asthma (age<16), excluding more controls

11.20

47.36

5.7

3.0

—

Systemic connective tissue disorders

356

1556

2.31

47.06

3.8

3.7

—

Liquid cancers

315

1230

2.45

46.93

3.8

3.7

—

Diseases of arteries, arterioles and capillaries

649

2555

1.88

46.37

3.6

3.7

—

Childhood asthma (age<16)

10.67

45.98

5.7

3.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

592

2793

1.90

45.96

3.7

3.9

—

Pulmonary embolism

327

1395

2.37

45.76

3.9

3.5

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

814

2996

1.75

45.30

3.6

4.0

—

Heart failure and coronary heart disease

460

1545

2.11

44.94

3.3

3.7

—

Disorders of lipoprotein metabolism and other lipidaemias

697

2320

1.84

44.90

3.6

3.8

—

Persons encountering health services for specific procedures, not carried out

117

280

4.27

44.42

3.9

3.8

—

Nasal polyp

207

717

2.93

44.31

5.6

3.6

—

Azathioprine

134

354

3.84

44.29

4.3

3.6

—

Pulmonary heart disease

327

1416

2.34

44.24

3.9

3.5

—

Oedema, not elsewhere classified

311

1285

2.39

44.08

3.6

3.7

—

Non-ischemic cardiomyopathy

338

1156

2.35

44.01

3.7

—

Explicit bacterial Sepsis, including avohilmo

147

417

3.60

43.89

3.3

3.8

—

Venous thromboembolism

529

2650

1.94

43.80

4.0

3.7

—

Mycoses

289

1193

2.45

43.56

4.9

3.6

—

Other diseases of intestines

776

2461

1.76

43.04

3.8

4.0

—

Acute renal failure

267

1073

2.53

42.75

3.6

3.5

—

Chronic kidney disease

362

1593

2.21

42.66

3.5

3.6

—

Complications of surgical and medical care, not elsewhere classified

812

3170

1.72

42.60

3.8

—

Benign neoplasm of colon, rectum, anus and anal canal

612

2828

1.84

42.50

4.0

3.7

—

Bronchitis, not specified as acute or chronic

200

4.84

42.30

3.8

3.2

—

Use of hypnotics and sedatives

843

2837

1.71

41.84

3.7

3.8

—

142

406

3.55

41.82

4.7

3.7

—

Explicit bacterial Sepsis

142

407

3.56

41.76

3.4

3.9

—

Ulcer of lower limb, not elsewhere classified

202

715

2.88

41.71

3.6

3.7

—

Dialysis, with operation codes

166

527

3.22

41.53

3.8

3.6

—

Cardiovascular diseases (excluding rheumatic etc)

361

907

2.29

41.28

4.5

4.3

—

Pure hypercholesterolaemia

645

2257

1.83

41.16

3.5

3.8

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

213

511

2.91

41.07

4.1

3.7

—

Streptococcal septicaemia, including avohilmo

129

351

3.76

41.07

3.4

—

Vocal cord dysfunction

128

297

3.84

40.90

3.3

3.8

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

409

1911

2.06

40.56

4.3

4.1

—

Invasive ventilation

110

270

4.19

40.51

3.4

3.7

—

Substance use, excluding alcohol

189

656

2.92

40.31

4.0

—

Fall on same level

854

2708

1.69

40.20

3.7

4.0

—

Vasomotor and allergic rhinitis

269

1086

2.44

40.17

4.4

4.0

—

Substance abuse, excluding more controls

476

2039

1.96

40.12

3.9

—

Viral pneumonia (known virus, not influenza)

7.10

39.76

4.8

3.6

—

Allergic conjunctivitis

424

2035

2.02

39.58

4.2

4.1

—

Special screening examination for infectious and parasitic diseases

177

417

3.12

39.29

4.4

3.7

—

Pneumothorax

104

251

4.25

39.17

4.8

3.6

—

Streptococcal septicaemia

124

340

3.73

39.05

3.4

—

Biological medicines for asthma

8.53

38.78

5.1

3.4

—

Hypertensive diseases (excluding secondary)

321

803

2.34

38.76

3.9

—

Acute tubulo-interstitial nephritis

530

2409

1.87

38.59

3.7

3.9

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

120

326

3.81

38.50

3.2

3.7

—

Liquid cancers, including Hilmo

343

1401

2.18

38.49

3.7

3.8

—

Other bacterial intestinal infections, including avohilmo

238

956

2.52

38.14

4.2

3.7

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

711

3257

1.71

37.73

4.2

3.9

—

Reimbursement for rheumatic diseases

473

2496

1.90

37.07

4.0

3.8

—

Enlarged lymph nodes

157

517

3.08

36.82

3.8

—

Conjunctivitis

558

2489

1.81

36.73

4.2

4.0

—

Bacterial intestinal infections, IBD co-morbidities

200

754

2.69

36.57

4.3

3.4

—

Disorders of conjunctiva

631

2807

1.75

36.55

4.1

4.0

—

Atrial fibrillation and flutter with reimbursement

219

514

2.71

36.40

3.6

3.9

—

Other bacterial intestinal infections

198

745

2.69

36.35

4.3

3.5

—

Adjustment and management of implanted device

216

851

2.58

36.17

3.3

3.6

—

Nephropathy related operations

157

524

3.06

36.14

3.5

3.7

—

Gout

308

1207

2.21

35.76

3.4

3.7

—

Parasetamol

490

1283

1.94

35.73

3.6

4.2

—

Other symptoms and signs involving the circulatory and respiratory systems

143

5.20

35.40

3.3

3.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

753

3037

1.66

35.34

3.9

—

Cardiovascular diseases

319

750

2.27

35.11

4.5

—

Pain in joint

437

1370

1.97

34.99

4.0

4.3

—

Spondylopathies

645

2201

1.74

34.83

3.6

3.8

—

Atrial fibrillation and flutter

237

609

2.53

34.80

3.3

3.9

—

Pneumonia due to Streptococcus pneumoniae

6.84

34.50

3.6

3.1

—

Unspecified chronic bronchitis

6.56

34.27

5.0

2.7

—

Factors influencing health status and contact with health services

219

407

2.72

34.17

4.4

3.7

—

Sarcoidosis

151

509

3.02

34.14

3.6

3.9

—

Abnormalities of heart beat

238

973

2.39

34.03

3.5

3.8

—

Other necrotizing vasculopathies

109

303

3.70

33.79

4.8

3.8

—

Paroxysmal tachycardia

173

514

2.82

33.44

3.7

4.0

—

Other antidepressants

789

2464

1.64

33.22

3.7

4.0

—

Symptoms and signs involving the digestive system and abdomen

733

2204

1.67

33.08

3.6

4.0

—

Hernia

716

2885

1.66

33.04

3.7

3.9

—

Syncope and collapse

370

1554

2.00

33.03

3.6

3.8

—

Cerebrovascular diseases (FINNGEN)

222

623

2.52

32.98

3.9

—

Mental and behavioural disorders due to psychoactive substance use

489

2492

1.81

32.62

3.9

—

Other special examinations and investigations of persons without complaint or reported diagnosis

461

1225

1.92

32.51

4.5

3.7

—

Abdominal and pelvic pain

729

2204

1.67

32.51

3.6

4.0

—

Other necrotizing vasculopathies (FG)

243

3.98

32.37

4.6

3.9

—

Diseases of the skin and subcutaneous tissue

702

2102

1.68

32.35

4.2

3.8

—

Benzodiazepine use

772

3243

1.61

32.22

3.9

3.8

—

DVT of lower extremities and pulmonary embolism

402

2116

1.91

32.12

3.8

3.7

—

Sleep apnoea

743

2881

1.63

32.11

3.8

3.9

—

Complications of medical and surgical care

599

3185

1.70

32.07

3.8

—

Other diseases of blood and blood-forming organs, wide

219

920

2.41

31.96

3.7

—

Substance abuse

476

2460

1.81

31.87

3.9

—

Open wound of lower leg

167

617

2.75

31.86

4.7

3.7

—

Headache

437

1810

1.87

31.81

3.9

4.0

—

Secondary right heart disease

182

4.51

31.81

3.5

3.6

—

Benign neoplasm: Colon

512

2737

1.77

31.75

4.1

3.7

—

Primary_lymphoid and hematopoietic malignant neoplasms

254

1142

2.25

31.67

3.6

—

Cardiomyopathy

177

675

2.65

31.66

3.6

3.7

—

Other pulmonary heart/vessel disease

200

4.30

31.51

3.4

4.1

—

Neoplasms

462

1292

1.88

31.34

4.3

4.1

—

Disorders of eyelid, lacrimal system and orbit

690

3107

1.63

30.85

3.9

3.8

—

Infections of the skin and subcutaneous tissue

461

2542

1.79

30.41

4.3

3.9

—

Malignant neoplasm, wide definition

609

2091

1.70

30.38

3.6

4.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

716

2797

1.62

30.35

3.7

3.9

—

Malignant neoplasm, including Hilmo

608

2089

1.70

30.32

3.6

4.0

—

Other disorders of skin and subcutaneous tissue

603

3060

1.67

30.14

3.7

3.8

—

Chronic viral hepatitis

133

5.00

30.09

3.7

4.1

—

Persons encountering health services for examination and investigation

455

1225

1.87

29.95

3.9

3.7

—

Cardiac arrhythmias

376

1239

1.95

29.87

3.5

4.2

—

Abnormal findings on examination of blood, without diagnosis

436

2180

1.82

29.84

4.2

3.6

—

Other viral hepatitis, including avohilmo

175

4.37

29.55

3.7

3.9

—

Low back pain

576

2297

1.70

29.51

3.7

4.0

—

Emergency coronary revascularization (for ACS)

679

2516

1.64

29.44

3.4

3.9

—

Other CVD (FINNGEN)

118

275

3.32

29.27

3.6

4.0

—

Other external causes of accidental injury

562

1625

1.74

29.26

3.7

3.9

—

Pain (limb, back, neck, head abdominally)

511

1439

1.79

29.12

3.4

4.2

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

8.19

29.11

3.3

4.0

—

Complications of procedures, not elsewhere classified

630

3109

1.64

29.04

3.9

3.8

—

Percutaneous Coronary Intervention

611

2228

1.68

29.04

3.4

3.9

—

Other disorders of urethra and urinary system

542

2216

1.71

28.52

3.8

3.9

—

Hard cardiovascular diseases

618

2204

1.66

28.47

3.6

3.9

—

Disorders of thyroid, IBD co-morbidities

117

242

3.33

28.46

3.6

3.3

—

Other systemic involvement of connective tissue (FG)

232

1030

2.23

28.40

3.4

3.9

—

Ischemic heart diseases

628

2269

1.66

28.38

3.6

3.9

—

Pulmonary eosinophilia, not elsewhere classified

9.02

28.26

4.1

—

Sleep disorders (combined)

813

2729

1.56

28.22

3.6

4.0

—

Seropositive rheumatoid arthritis

229

1029

2.24

28.20

4.0

3.8

—

Gout, FINNGEN

308

1548

2.00

28.16

3.4

3.6

—

Hyperlipidaemia, other/unspecified

366

1753

1.89

28.13

3.5

3.8

—

Dermatitis and eczema

832

3206

1.54

28.03

4.0

3.8

—

Injuries to the thorax

413

2300

1.81

27.96

3.7

—

Follow-up examination after treatment for conditions other than malignant neoplasms

314

1037

2.03

27.90

3.5

3.6

—

Asthma mixed form (mode), excluding more controls

10.83

27.78

4.7

2.8

—

Mood disorders, excluding more controls

686

2515

1.61

27.71

4.0

3.9

—

Gout, unspecified

230

1055

2.21

27.43

3.4

3.6

—

Need for immunization against other single viral diseases

7.30

27.39

5.1

4.1

—

Gout, idiopatic and unspecified

271

1325

2.07

27.35

3.4

3.6

—

Other viral hepatitis

169

4.29

27.30

3.6

3.9

—

Gastrointestinal diseases

354

903

1.97

27.24

4.3

4.0

—

Coronary revascularization (ANGIO or CABG)

603

2229

1.65

27.12

3.4

3.9

—

Other arrhythmias

444

1880

1.77

26.88

3.5

4.1

—

Anxiety disorders, excluding more controls

581

2248

1.66

26.88

4.1

3.9

—

Spondylosis

452

2022

1.76

26.78

3.7

3.8

—

Methotrexate

113

372

3.07

26.66

3.5

3.4

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

7.28

26.57

4.0

3.6

—

Diseases of oral cavity, salivary glands and jaws

464

1346

1.79

26.57

3.7

—

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

7.28

26.57

4.0

3.6

—

Rheumatoid arthritis

277

1216

2.03

26.24

4.0

3.8

—

Non-small cell lung cancer, squamous

210

3.86

26.22

3.1

3.8

—

Malignant neoplasm

583

2074

1.65

26.21

3.6

3.9

—

Sulfasalazine

188

809

2.34

26.01

3.5

3.4

—

Peripheral artery disease

417

1861

1.78

25.99

3.9

3.6

—

Asthma mixed form (mode)

9.78

25.89

4.7

2.7

—

Other specific joint derangements/joint disorders

510

1877

1.70

25.82

4.0

4.1

—

Persons with potential health hazards related to communicable diseases

237

1114

2.12

25.76

4.5

4.2

—

Intracranial trauma

393

1462

1.82

25.72

3.6

4.3

—

Malignant neoplasm

580

2073

1.64

25.62

3.6

3.9

—

Endocrine, nutritional and metabolic diseases

500

1466

1.73

25.60

3.9

4.3

—

Other immunodeficiencies

9.47

25.36

7.5

4.3

—

Accidents

544

1625

1.68

25.32

3.7

3.9

—

Symptoms and signs involving the urinary system

612

2900

1.60

25.28

3.9

3.8

—

Atherosclerosis, excluding cerebral and coronary sclerosis

399

1765

1.79

25.15

3.7

3.5

—

Conjunctivitis (acute, non atopic), including avohilmo

723

2827

1.55

25.10

3.9

—

Benign neoplasms

676

2343

1.58

24.70

4.2

3.8

—

Allergic rhinitis

201

900

2.22

24.50

3.9

4.3

—

Lung diseases due to external agents

168

709

2.40

24.47

3.6

—

Other and unspecified iron deficiency

306

1621

1.90

24.33

3.7

—

Dorsalgia

689

2341

1.56

24.32

3.7

4.0

—

Depression

671

2892

1.56

24.27

4.0

3.9

—

Finngen Rheumatological endpoints

642

2309

1.58

24.20

3.6

4.0

—

Need for other prophylactic measures

199

3.80

24.16

4.2

3.7

—

Iron deficiency anaemia

375

2082

1.78

24.11

3.6

3.7

—

Hypertension, essential

508

1717

1.68

24.10

3.8

4.0

—

Viral hepatitis, including avohilmo

227

3.59

24.08

3.7

4.2

—

Depression medications

137

240

2.88

23.93

4.2

5.3

—

Viral infections characterized by skin and mucous membrane lesions

332

1817

1.84

23.89

4.0

3.8

—

Hypertensive diseases

511

1735

1.67

23.64

3.8

4.0

—

Alcohol use disorder, Swedish definition

435

2338

1.70

23.61

3.8

3.7

—

Nutritional anaemias

427

2402

1.70

23.56

3.6

3.7

—

Neurological diseases, wide definition

152

285

2.69

23.53

4.0

3.8

—

Candidiasis

133

512

2.63

23.52

5.4

3.9

—

Other systemic involvement of connective tissue

239

1180

2.04

23.52

3.4

3.7

—

Human immunodeficiency virus [HIV] disease

6.36

23.51

4.0

3.5

—

Any mental disorder

779

2584

1.51

23.51

3.8

3.9

—

Hernia of abdominal wall, postoperative

147

592

2.49

23.24

4.0

3.5

—

Mental and behavioural disorders due to opioids

5.48

23.14

4.3

3.8

—

Neurotic, stress-related and somatoform disorders

601

2636

1.58

23.11

4.0

—

Anxiety disorders

609

2669

1.57

23.06

4.0

—

Hypertension

508

1735

1.66

22.99

3.8

4.0

—

Major coronary heart disease event

629

2410

1.57

22.98

3.4

3.9

—

Human immunodeficiency virus [HIV] disease, including avohilmo

6.16

22.83

4.0

3.5

—

Shoulder lesions

553

2065

1.61

22.68

3.6

3.8

—

Periodontitis

732

3108

1.51

22.61

4.0

3.8

—

Soft tissue disorders

673

2234

1.55

22.54

3.7

4.0

—

Other and unspecified dermatitis

403

2380

1.70

22.36

4.0

3.8

—

Osteoporosis with pathological fracture (FG)

269

3.26

22.28

4.2

3.6

—

Disorders of lens

520

1993

1.63

22.26

3.5

3.9

—

Other cataract

380

1623

1.75

22.16

3.9

3.8

—

Chronic periodontitis, including avohilmo

729

3110

1.50

22.15

4.0

3.8

—

Other diseases of urinary system

703

2605

1.52

22.13

3.8

3.9

—

Mood disorders

716

3054

1.50

22.00

3.9

—

Cardiomyopathy, other and unspecified

293

3.13

21.82

3.6

4.1

—

Viral hepatitis

218

3.50

21.81

3.5

4.2

—

Spinal stenosis

435

1920

1.68

21.80

3.6

3.8

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

244

760

2.03

21.73

4.4

3.9

—

Mood [affective] disorders

713

3053

1.50

21.70

4.0

3.9

—

Enterocolitis due to Clostridium difficile

124

481

2.62

21.69

4.9

3.4

—

Solid cancers, including Hilmo

563

2073

1.59

21.69

3.5

3.9

—

Other disorders of fluid, electrolyte and acid-base balance

279

1403

1.89

21.65

3.6

3.7

—

Nonhereditary hypogammaglobulinemia

8.36

21.54

4.3

4.0

—

Sleep apnoea, including avohilmo

722

2929

1.50

21.39

3.9

—

Anxiety (asthma-related co-morbidities)

375

1650

1.73

21.35

4.1

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

174

3.79

21.34

3.4

4.0

—

Seropositive rheumatoid arthritis, wide

229

1156

2.00

21.25

4.0

3.7

—

Any event in cancer register

591

2218

1.56

21.20

3.7

3.9

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

352

2016

1.74

21.17

3.9

3.7

—

Polyneuropathies and other disorders of the peripheral nervous system

211

1037

2.06

21.13

3.4

3.6

—

Seropositive rheumatoid arthritis, strict definition

141

589

2.42

21.06

4.1

3.7

—

Other diseases of pericardium

158

3.95

21.06

3.7

4.2

—

STROKE

394

1554

1.71

21.03

3.7

3.9

—

Other/unspecified seropositive rheumatoid arthritis

227

1147

2.00

21.02

4.0

3.7

—

Other dorsopathies, not elsewhere classified

682

2343

1.52

20.95

3.7

4.0

—

Injuries to the head

786

3193

1.46

20.95

3.6

4.0

—

Fracture of rib(s), sternum and thoracic spine

274

1477

1.87

20.89

3.7

3.6

—

Dermatitis

467

2850

1.61

20.82

4.0

3.8

—

Depression or dysthymia

487

1634

1.63

20.79

3.9

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

475

2924

1.60

20.67

3.8

—

Other disorders of white blood cells

202

3.55

20.66

3.7

4.1

—

Other disorders of veins

325

1819

1.77

20.66

3.8

—

Respiratory tuberculosis, not confirmed, including avohilmo

179

3.73

20.62

4.4

3.9

—

Deviated nasal septum

247

1292

1.92

20.55

3.7

3.5

—

Other functional intestinal disorders

350

1843

1.73

20.53

3.8

3.9

—

Pneumonia derived septicemia

102

4.73

20.41

4.0

3.3

—

Episodal and paroxysmal disorders

734

2513

1.49

20.38

3.6

4.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

222

1126

1.99

20.35

4.0

3.7

—

444

2450

1.63

20.35

3.8

—

Concussion

331

1458

1.77

20.23

3.6

4.3

—

Chronic laryngitis and laryngotracheitis

123

493

2.52

20.10

4.6

3.6

—

Sequelae of tuberculosis

5.42

20.04

6.5

3.7

—

Mental and behavioural disorders due to alcohol

386

2208

1.67

20.01

3.9

3.8

—

Lower back pain or/and sciatica

760

3251

1.46

19.95

3.8

3.9

—

Other inflammation of eyelid, including avohilmo

301

1695

1.78

19.85

3.5

3.9

—

458

2494

1.60

19.83

3.8

—

Symptoms and signs concerning food and fluid intake

103

380

2.74

19.81

4.0

3.8

—

All anxiety disorders

381

1760

1.69

19.72

4.1

—

Gingivitis and periodontal diseases

710

2478

1.48

19.71

3.9

3.8

—

Non-small cell lung cancer, squamous, helper endpoint

254

3.19

19.67

3.1

3.7

—

Cardiodefibrillation

329

1903

1.74

19.65

3.5

3.6

—

Congenital malformations of the respiratory system

5.88

19.63

4.1

3.5

—

Other and unspecified polyneuropathies, also in other diseases

189

918

2.08

19.60

3.5

3.7

—

Other noninfective gastroenteritis and colitis

200

991

2.03

19.54

4.5

3.8

—

Used for control exclusion in common control thyroid runs

709

2420

1.48

19.42

3.7

4.0

—

Valvular heart disease excluding rheumatic fever

348

1445

1.73

19.38

3.7

3.9

—

Falls/tendency to fall

691

2331

1.49

19.38

3.5

4.1

—

Cystitis

591

2310

1.53

19.32

3.4

3.8

—

Nausea and vomiting

213

1057

1.98

19.24

4.4

4.1

—

Cellulitis

186

904

2.08

19.22

4.5

3.8

—

Autoimmune diseases

750

2612

1.46

19.22

3.8

4.0

—

Sequelae of tuberculosis, including avohilmo

5.21

19.21

6.5

3.6

—

Rotator cuff syndrome

458

1972

1.61

19.17

3.5

3.8

—

Diseases of the eye and adnexa

460

1419

1.63

19.12

4.0

4.2

—

Budesonide

354

2.76

19.11

3.8

3.5

—

Respiratory tuberculosis, not confirmed

179

3.62

19.10

4.0

3.9

—

Non-rheumatic valve diseases

346

1441

1.72

19.03

3.7

3.9

—

Other anxiety disorders

280

1319

1.81

19.02

4.1

—

External causes of morbidity and mortality

418

1260

1.67

19.02

4.0

3.9

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

143

630

2.29

18.94

4.0

3.7

—

Cardiomyopathy (excluding other)

118

478

2.50

18.90

3.6

3.8

—

Hypertensive heart and/or renal disease

242

929

1.92

18.89

3.6

3.8

—

In situ neoplasms

332

1955

1.71

18.78

4.1

3.7

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

698

3027

1.46

18.73

3.9

3.8

—

Cerebrovascular diseases

588

2714

1.51

18.70

3.7

3.8

—

Problems related to lifestyle

298

2.92

18.69

3.8

3.6

—

Cystic fibrosis

47.54

18.62

21.0

2.3

—

Senile cataract

481

1854

1.58

18.59

3.5

3.8

—

Congenital malformations of the respiratory system, including avohilmo

5.43

18.59

4.1

3.7

—

Congenital malformations of trachea and bronchus

7.32

18.52

4.1

3.5

—

Solid cancers

537

2045

1.54

18.48

3.5

3.9

—

Poisoning by drugs, medicaments and biological substances

162

759

2.15

18.43

3.5

4.2

—

Non-Hodgkin lymphoma, all, including Hilmo

127

539

2.39

18.39

3.3

3.9

—

Other viral diseases, including avohilmo

236

1251

1.88

18.36

3.4

4.1

—

Other arthritis (FG)

234

1251

1.88

18.36

4.0

3.8

—

Type 2 diabetes, wide definition

603

2545

1.50

18.35

3.4

3.9

—

Drug-induced osteoporosis with pathological fracture

5.26

18.32

3.9

3.5

—

Cardiomyopathies, Primary/intrinsic

113

457

2.50

18.18

3.5

3.9

—

Diseases of the musculoskeletal system and connective tissue

315

889

1.78

18.14

3.8

4.5

—

Unspecified haematuria

363

1787

1.66

18.00

3.9

3.6

—

Dizziness and giddiness

547

2824

1.51

17.97

3.6

3.8

—

Convulsions, not elsewhere classified

159

738

2.14

17.90

3.7

3.9

—

Benign neoplasm: Colon, unspecified

234

1266

1.87

17.77

4.1

3.6

—

Cutaneous abscess, furuncle and carbuncle

197

1007

1.97

17.71

4.2

3.8

—

Other/unspecified dorsalgia

272

1521

1.78

17.65

3.7

3.9

—

Alcohol dependence

217

1148

1.90

17.63

3.8

3.7

—

Chronic periodontitis, complicated

437

2725

1.57

17.63

3.9

3.8

—

Chronic lymphocytic leukaemia, helper endpoint

133

3.96

17.57

3.6

4.1

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

133

3.96

17.57

3.6

4.1

—

Chronic lymphocytic leukaemia

133

3.96

17.57

3.6

4.1

—

Soft tissue disorders related to use, overuse and pressure

222

1185

1.89

17.54

3.7

3.8

—

Other diseases of oesophagus

102

401

2.58

17.46

3.8

3.7

—

Other gastritis (incl. Duodenitis)

188

952

1.99

17.40

3.7

3.6

—

Carrier of infectious disease

4.85

17.40

5.2

3.5

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

151

705

2.16

17.38

4.0

3.7

—

Diseases of liver

277

1586

1.76

17.38

3.6

3.7

—

Atopic dermatitis

361

1751

1.65

17.28

4.1

4.0

—

Gout, strict definition

189

964

1.98

17.20

3.3

3.7

—

Non-selective monoamine reuptake inhibitors

279

1538

1.75

17.17

3.8

—

Noninfective enteritis and colitis

330

1985

1.67

17.16

4.2

3.8

—

Wegener granulomatosis

5.78

17.14

6.1

3.9

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

369

1521

1.65

17.01

3.8

3.9

—

Disorders of oesophagus in diseases classified elsewhere

4.98

16.98

5.6

4.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

319

1884

1.68

16.90

3.7

3.8

—

Ethmoidectomy

110

455

2.44

16.89

6.2

3.6

—

Conduction disorders

233

1014

1.85

16.78

3.4

3.7

—

Atopic dermatitis, strict definition with reimbursement

171

812

2.03

16.77

4.2

4.0

—

Rheumatoid arthritis, including avohilmo

293

1722

1.71

16.76

4.0

3.7

—

Symptoms and signs involving the skin and subcutaneous tissue

513

3241

1.50

16.75

4.0

3.8

—

Endocarditis

120

4.01

16.62

3.5

4.1

—

Kidney transplant status

186

3.35

16.59

4.1

4.4

—

Poisoning by medicine

143

666

2.16

16.58

3.6

4.2

—

Pollen allergy

109

446

2.42

16.52

4.1

4.5

—

ILD medications: nintedanib

14.02

16.47

3.6

3.1

—

Memory loss

107

444

2.45

16.40

3.6

3.7

—

Sequelae of external causes of morbidity and mortality

214

1155

1.87

16.40

3.6

—

Hypothyroidism (congenital or acquired)

103

218

2.65

16.32

3.6

4.2

—

Other viral diseases

189

978

1.94

16.24

3.6

4.1

—

L01XE Protein kinase inhibitors

225

3.09

16.20

3.5

3.9

—

Urinary track infection

309

898

1.73

16.11

3.9

4.1

—

Other diseases of hard tissues of teeth

408

1324

1.60

16.08

3.5

3.7

—

Hypothyroidism and >3 levothyroxin purchases

102

217

2.64

16.05

3.6

4.2

—

Hypothyroidism, levothyroxine purchases

102

217

2.64

16.05

3.6

4.2

—

Hypertensive Heart Disease

218

891

1.87

15.99

3.6

3.8

—

Alcohol use disorder, ICD-based

315

1912

1.66

15.97

3.8

3.7

—

Other headache syndromes

271

1575

1.72

15.93

4.4

4.0

—

Herpesviral [herpes simplex] infections, including avohilmo

171

865

1.99

15.90

4.7

3.9

—

Kela reimbursement Agammaglobulinemia (D80-84)

12.64

15.88

4.7

3.1

—

Fracture of lumbar spine and pelvis

202

1081

1.88

15.79

3.6

3.5

—

Personality disorders, excluding more controls

146

698

2.10

15.72

3.4

4.2

—

Pericarditis

116

3.97

15.72

3.6

4.0

—

Chronic apical periodontitis

753

3025

1.40

15.69

3.8

4.0

—

Sicca syndrome [Sjögren]

289

2.77

15.64

3.9

3.7

—

Other CVD

199

1069

1.88

15.53

3.8

3.5

—

Carcinoma in situ of skin of other and unspecified parts of face

108

462

2.38

15.51

4.4

3.6

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

337

2.62

15.43

3.7

3.4

—

Hypotension

182

952

1.93

15.42

3.6

3.5

—

Other viral diseases, not elsewhere classified, including avohilmo

177

911

1.94

15.36

3.5

4.1

—

Care involving dialysis

304

2.71

15.29

4.9

3.7

—

Myocarditis

105

4.06

15.23

3.5

3.9

—

FESS (DNB20)

103

435

2.39

15.16

6.0

3.6

—

Polypectomy (DHB20)

278

2.78

15.10

4.5

3.7

—

Unspecified kidney failure

116

518

2.27

15.05

3.0

3.6

—

Progressive vascular leukoencephalopathy

193

3.19

15.04

3.0

3.5

—

Angina pectoris

435

1892

1.53

14.90

3.3

3.8

—

Ischaemic heart disease, wide definition

557

2357

1.46

14.90

3.6

3.8

—

Noninfectious colitis NAS

116

520

2.25

14.87

3.9

3.8

—

Other specified/unspecified arthritis

203

1112

1.84

14.87

3.9

—

Injuries to the hip and thigh

394

2293

1.55

14.85

3.7

3.8

—

Other infectious diseases, including avohilmo

385

2.48

14.84

3.7

3.8

—

Other diseases of lip and oral mucosa

299

1828

1.64

14.78

3.9

3.8

—

Other infectious diseases

327

2.61

14.77

3.7

3.6

—

Nonorganic sleeping disorders, excluding more controls

133

631

2.12

14.76

3.7

4.1

—

Other and unspecified disorders of white blood cells

155

3.43

14.72

3.7

—

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

6.66

14.72

4.6

3.3

—

Psychiatric diseases

657

2320

1.42

14.72

3.8

4.0

—

Polyuria

198

1081

1.85

14.70

3.7

3.5

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

347

1472

1.61

14.70

3.7

3.9

—

Sequelae with surgical and medical care as external cause

173

905

1.93

14.67

3.5

3.6

—

Pleural plaque

100

424

2.39

14.65

3.7

3.4

—

Unspecified human immunodeficiency virus [HIV] disease

6.94

14.64

4.7

3.3

—

Disorders of gallbladder, biliary tract and pancreas

696

3111

1.40

14.63

4.0

3.8

—

Abnormal weight loss

415

2.39

14.40

4.1

3.8

—

Disorders of lacrimal system

313

1916

1.61

14.36

3.9

3.8

—

Benign neoplasm of other and ill-defined parts of digestive system

157

801

1.98

14.36

3.9

3.7

—

Diseases of the digestive system

366

2346

1.56

14.35

4.2

3.7

—

Zoster [herpes zoster], including avohilmo

395

2504

1.53

14.26

4.1

3.8

—

Sequelae of infectious and parasitic diseases

281

2.71

14.23

5.6

3.8

—

Weight loss

101

436

2.35

14.21

4.1

3.8

—

Adverse effects, not elsewhere classified

138

676

2.06

14.11

3.6

4.2

—

Overexertion and strenuous or repetitive movements

358

2.49

14.10

3.5

3.9

—

Other viral diseases, not elsewhere classified

130

623

2.09

13.96

3.7

4.0

—

GI-bleeding

271

1643

1.66

13.89

3.7

3.5

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

425

2850

1.49

13.82

3.9

3.8

—

Other reaction to severe stress, and adjustment disorders

205

1151

1.79

13.81

4.6

4.0

—

Other arthrosis

383

1666

1.55

13.78

3.6

3.8

—

Other symptoms and signs involving cognitive functions and awareness

382

2222

1.53

13.73

3.5

3.8

—

Other diseases of anus and rectum

232

1349

1.72

13.71

4.0

3.7

—

Coagulation defects, purpura and other haemorrhagic conditions

154

794

1.95

13.66

3.4

3.8

—

Sequelae of infectious and parasitic diseases, including avohilmo

288

2.64

13.58

5.6

3.7

—

Pneumococcal septicemia

129

3.57

13.56

3.8

—

Recurrent or chronic depression

237

951

1.74

13.56

4.4

4.2

—

Disorders of synovium and tendon

346

1887

1.56

13.52

3.6

3.9

—

Non-Hodgkin lymphoma, all

190

3.06

13.46

2.8

3.9

—

Abnormal results of function studies

238

2.80

13.46

3.7

—

Other diseases of the digestive system

269

1642

1.65

13.45

3.7

3.5

—

Irritable bowel syndrome

177

961

1.85

13.39

3.6

4.0

—

Neurological diseases

516

1779

1.46

13.37

3.6

4.2

—

Diseases of salivary glands

231

1357

1.71

13.36

4.0

3.8

—

Unspecified fall

379

2459

1.52

13.36

3.8

3.9

—

Non-allergic asthma

302

2.58

13.32

3.8

4.5

—

Cytomegalovirus infection, IBD co-morbidity

4.41

13.21

3.0

3.7

—

Abnormal findings on diagnostic imaging of other body structures

431

2.29

13.19

5.4

3.4

—

Basal cell carcinoma, including Hilmo

342

1483

1.57

13.14

3.8

3.9

—

Statin medication

401

1487

1.52

13.06

4.0

4.2

—

Selective serotonin reuptake inhibitors

657

2466

1.39

13.02

3.8

4.0

—

Stomatitis and related lesions

146

754

1.95

12.91

3.5

3.9

—

Injuries to the knee and lower leg

786

3166

1.34

12.86

3.8

3.9

—

Cytomegaloviral disease

4.21

12.85

3.0

4.1

—

Injury, poisoning and certain other consequences of external causes

324

1017

1.60

12.82

4.1

—

Other disorders of lacrimal gland

261

1602

1.64

12.79

3.8

—

Cytomegaloviral disease, including avohilmo

4.16

12.65

3.0

4.1

—

Other intervertebral disc disorders

539

2265

1.42

12.62

3.7

3.9

—

Other nutritional deficiencies

422

2630

1.47

12.60

3.4

3.9

—

Respiratory tuberculosis, clinically confirmed

5.22

12.55

4.8

3.4

—

Mental and behavioural disorders due to sedatives or hypnotics

203

2.89

12.54

3.3

4.0

—

Eosinophilic disease (BM)

20.55

12.52

3.9

2.9

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

342

2.43

12.51

3.4

3.9

—

Dorsopathies

640

2346

1.38

12.44

3.7

4.0

—

Carcinoma in situ of skin

431

2.26

12.41

4.1

3.6

—

Lymphoid leukaemia

250

2.69

12.35

3.7

3.9

—

Basal cell carcinoma

329

1446

1.56

12.34

3.8

3.9

—

Other diseases of intestine

130

656

2.00

12.33

3.7

3.6

—

Acetic acid derivatives and related substances

208

605

1.79

12.31

3.5

4.4

—

Other disorders of eyelid

352

2200

1.52

12.29

3.8

3.7

—

Ptosis of eyelid

104

484

2.17

12.28

4.1

3.6

—

Other inflammation of eyelid

118

576

2.07

12.28

3.8

3.7

—

Coronary atherosclerosis

459

1997

1.45

12.25

3.5

3.8

—

Functional dyspepsia

186

1055

1.77

12.24

3.8

—

Visual disturbances

347

2299

1.52

12.21

4.1

3.8

—

Major coronary heart disease event excluding revascularizations

450

2050

1.45

12.07

3.4

3.8

—

Other or ill-defined heart diseases

170

3.04

12.03

3.7

4.5

—

Myalgia

158

858

1.85

12.01

3.8

—

Glomerular diseases

146

774

1.90

12.00

4.5

3.5

—

Other disorders of adrenal gland

155

3.15

11.99

5.2

3.8

—

Haemorrhage, not elsewhere classified

145

3.23

11.96

3.8

3.3

—

Malignant neoplasm of skin, including Hilmo

368

1640

1.51

11.91

3.8

3.9

—

Dermatophytosis, including avohilmo

433

2951

1.44

11.84

3.8

—

Adrenocortical insufficiency

131

3.35

11.82

5.6

3.6

—

Obesity, other/unspecified

206

1215

1.70

11.80

3.2

4.0

—

Antihypertensive medication - note that there are other indications

285

926

1.61

11.75

4.5

4.8

—

Personal history of allergy to drugs, medicaments and biological substances

5.72

11.75

7.0

3.8

—

Secondary hypertension

196

2.84

11.74

3.4

3.5

—

Other and unspecified effects of external causes

172

967

1.79

11.68

3.8

4.0

—

Other complications of surgical and medical care, not elsewhere classified

366

2.32

11.64

4.2

4.1

—

Fibromyalgia

234

2.67

11.64

3.5

3.6

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

147

778

1.87

11.61

3.9

4.1

—

Genitourinary diseases

354

1163

1.53

11.61

4.2

4.1

—

Recurrent aphthous stomatitis , including avohilmo

113

555

2.05

11.59

3.5

3.9

—

Malignant neoplasm of skin

352

1583

1.51

11.51

3.8

3.9

—

Conjunctivitis (acute, non atopic)

181

1033

1.75

11.50

3.9

4.0

—

Hypo-osmolality and hyponatraemia

148

794

1.86

11.44

3.6

3.7

—

Viral warts, including avohilmo

141

751

1.89

11.42

4.1

4.0

—

Trochanteric bursitis

114

567

2.03

11.30

3.7

3.9

—

Other and unspecified drugs and medicaments

328

2.38

11.26

3.2

3.9

—

Dental caries, including avohilmo

510

1855

1.41

11.17

3.6

3.8

—

Hereditary hypogammaglobulinemia

17.49

11.17

5.5

3.0

—

Other/unspecified cytomegaloviral diseases

4.27

11.16

3.2

4.0

—

Missing teeth due to accident, extraction or parodontitis

460

2917

1.41

11.14

3.7

3.8

—

Disorders of skin appendages

304

1988

1.53

11.12

4.4

3.9

—

Other disorders of the musculoskeletal system and connective tissue

125

647

1.95

11.09

3.3

3.8

—

Mental and behavioural disorders due to tobacco

319

2.38

11.01

4.4

4.0

—

Atopic dermatitis, strict definition

150

805

1.83

11.00

4.2

4.4

—

Disorder of lipoprotein metabolism, unspecified

115

583

1.99

10.85

3.1

3.8

—

Visual disturbances and blindness

367

2521

1.46

10.79

4.1

3.8

—

Oesophagitis

215

2.69

10.79

4.3

3.9

—

Non-invasive ventilation

130

589

1.91

10.73

4.2

4.0

—

Diabetes, varying definitions

644

2788

1.34

10.66

3.6

4.1

—

5-aminosalicylic acid

109

545

2.01

10.65

3.7

—

Paralytic ileus and intestinal obstruction

196

1176

1.67

10.57

4.1

3.6

—

Smoking dependency

326

2.33

10.51

4.4

4.0

—

Drug-induced adrenocortical insufficiency

4.18

10.50

4.7

4.0

—

Any operation in hilmo

13.51

10.50

4.2

9.8

—

Biological medication for rheuma

111

564

1.98

10.39

3.9

4.3

—

Respiratory disorders in diseases classified elsewhere

4.56

10.37

7.9

4.1

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

220

2.64

10.35

3.2

3.9

—

Reactive arthropathies, FINNGEN

237

2.56

10.35

4.7

4.0

—

Chronic pancreatitis

111

566

1.98

10.33

6.6

3.8

—

Fracture of femur

234

1327

1.60

10.33

3.5

3.6

—

347

2139

1.47

10.29

3.9

3.6

—

Sciatica+with lumbago

332

1995

1.48

10.28

3.8

3.9

—

Subjective visual disturbances

181

1073

1.70

10.27

3.7

—

Gastroduodenal ulcer

203

1236

1.65

10.27

3.6

3.5

—

Intestinal adhesions without obstruction

343

2.27

10.20

4.3

4.0

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

112

569

1.96

10.19

4.4

3.6

—

Osteonecrosis

258

2.48

10.11

3.9

3.8

—

Obesity

386

2556

1.43

9.98

3.3

3.9

—

Disorders of other endocrine glands

282

1840

1.51

9.97

4.1

3.9

—

Obesity and other hyperalimentation

388

2569

1.42

9.95

3.3

3.9

—

Drug-induced osteoporosis

4.41

9.95

4.5

4.0

—

Abnormalities of gait and mobility

112

581

1.95

9.94

3.2

3.7

—

Zoster [herpes zoster]

149

845

1.78

9.94

4.3

3.6

—

Personality disorders

146

823

1.78

9.91

3.4

4.2

—

Benign neoplasm: Sigmoid colon

158

915

1.74

9.82

3.8

3.6

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

467

2.05

9.78

3.7

4.1

—

Open wound of head

390

2592

1.42

9.77

3.6

3.9

—

AV-block

141

671

1.81

9.73

3.1

3.8

—

Fentanyl

401

2.13

9.72

3.3

3.8

—

Somatoform disorder

106

544

1.96

9.68

3.1

4.2

—

Lumbar disc prolapse

404

2122

1.41

9.65

3.8

3.9

—

Secondary and unspecified malignant neoplasm of lymph nodes

333

2.25

9.60

2.9

4.0

—

Dementia in Alzheimer disease

979

0.40

9.56

3.1

3.6

—

Diabetes mellitus

638

2797

1.32

9.49

3.6

4.1

—

Injuries to the shoulder and upper arm

576

3348

1.33

9.48

3.6

3.9

—

Skin changes due to chronic exposure to nonionizing radiation

329

2055

1.46

9.47

3.9

3.6

—

Pneumonitis due to solids and liquids

387

2.14

9.46

3.7

3.6

—

Injuries to the wrist and hand

645

3265

1.31

9.43

4.1

3.9

—

Other disorders of eye and adnexa

100

509

1.98

9.38

5.0

3.9

—

Papulosquamous disorders

264

1752

1.51

9.37

3.5

3.8

—

Transport accidents

264

1449

1.52

9.36

4.0

3.9

—

Preparatory care for dialysis

185

2.70

9.33

4.0

4.1

—

Diseases of pulp and periapical tissues, including avohilmo

671

2652

1.31

9.33

3.8

4.0

—

Nonorganic sleeping disorders

133

744

1.80

9.31

3.7

4.0

—

Other neurological diseases

515

2970

1.35

9.29

3.5

3.8

—

Herpesviral [herpes simplex] infections

411

2.08

9.20

4.0

3.9

—

Use of anticholinesterases

130

1745

0.57

9.19

3.5

3.6

—

N06DA Anticholinesterases

130

1745

0.57

9.19

3.5

3.6

—

Caries of dentine, including avohilmo

527

1992

1.36

9.18

3.6

3.8

—

Cervicalgia

143

822

1.75

9.13

3.5

3.9

—

Secondary uncertain malignant neoplasm

104

542

1.93

9.13

3.1

3.8

—

Myocardial infarction

353

1725

1.44

9.09

3.4

3.8

—

Cervical disc disorders

243

1596

1.53

9.07

4.1

3.9

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

106

3.26

9.06

4.7

3.8

—

Other specified/unspecified systemic involvement of connective tissue

200

2.58

8.99

3.3

3.6

—

Migraine with aura

122

672

1.82

8.97

4.8

4.3

—

Acute myeloid leukaemia and myelodysplastic syndromes

3.38

8.95

3.4

—

Presence of cardiac and vascular implants and grafts

351

1812

1.43

8.95

3.3

3.7

—

Extracorporeal dialysis

261

2.37

8.95

4.7

4.1

—

Personal history of allergy to analgesic agent

11.32

8.93

6.8

2.7

—

Actinic keratosis

321

2030

1.45

8.92

3.9

3.6

—

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

4.62

8.91

9.9

4.2

—

Suicide or other Intentional self-harm

143

828

1.74

8.91

3.9

4.0

—

Urticaria and erythema

213

1364

1.57

8.90

4.3

3.9

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

18.57

8.84

4.5

3.4

—

Sequelae of injuries, of poisoning and of other consequences of external causes

157

935

1.69

8.84

3.6

3.9

—

Aortic aneurysm

193

1187

1.60

8.83

3.3

3.6

—

Disorders of sclera, cornea, iris and ciliary body

355

2523

1.41

8.83

3.8

4.0

—

Gastric ulcer

138

794

1.75

8.81

3.4

3.5

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

124

692

1.81

8.81

4.6

3.6

—

Disturbances of skin sensation

165

997

1.66

8.78

3.7

3.9

—

Superficial injury of thorax

115

628

1.84

8.76

3.5

3.7

—

Retention of urine

271

1476

1.49

8.72

4.0

3.5

—

Nerve, nerve root and plexus disorders

695

3248

1.29

8.71

3.5

3.9

—

Tuberculosis of other organs

3.46

8.70

5.8

3.6

—

Common variable immunodeficiency

9.56

8.70

4.6

3.5

—

Ischaemic Stroke, excluding all haemorrhages

430

2312

1.37

8.69

3.5

3.7

—

Other specified/unspecified bacterial intestinal infections

252

2.37

8.68

3.2

3.4

—

Other bacterial agents as the cause of diseases classified to other chapters

4.94

8.68

8.4

4.1

—

Other and unspecified coagulation defects

152

2.80

8.66

3.2

3.6

—

Dental operations

438

1634

1.38

8.66

3.7

—

Other superficial mycoses, including avohilmo

341

2.16

8.66

4.2

4.0

—

Disorders of adult personality and behaviour

147

865

1.71

8.64

3.3

4.2

—

Systemic lupus erythematosus

120

3.05

8.62

2.6

3.5

—

Other inflammatory liver diseases

253

2.36

8.61

3.0

3.9

—

Exposure to other specified factors

495

3186

1.34

8.61

3.8

4.0

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

131

2.95

8.58

4.3

3.7

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

3.88

8.57

3.2

3.6

—

Injuries to the ankle and foot

418

2610

1.37

8.56

4.0

—

Volume depletion

403

2.05

8.54

3.6

3.8

—

Paracetamol or NSAID medication

245

2.03

8.53

3.9

5.4

—

Intracranial injury

391

2643

1.38

8.53

3.5

3.9

—

Squamous cell neoplasms and carcinomas of the skin

466

1.97

8.44

4.5

3.7

—

Sequelae of injuries of lower limb

332

2.16

8.42

3.2

4.1

—

Defects in the complement system

9.94

8.40

5.8

3.7

—

Pain in thoracic spine

103

551

1.88

8.38

4.0

3.9

—

Benign neoplasm: Other and unspecified parts of small intestine

3.73

8.37

6.1

4.0

—

Striking against or struck by other objects

203

1304

1.56

8.36

4.3

4.1

—

Type 2 diabetes

617

2753

1.30

8.30

3.4

4.0

—

SLE (Finngen)

123

2.98

8.27

2.6

4.0

—

Intracranial and intraspinal abscess and granuloma

4.51

8.23

3.1

3.5

—

Stroke, including SAH

465

2489

1.34

8.21

3.6

3.7

—

Exclusions for E4_PCOS_BROAD

112

619

1.82

8.20

4.2

4.0

—

Abnormal serum enzyme levels

239

1543

1.50

8.20

4.1

3.5

—

Hypothyroidism, drug reimbursement

157

2.45

8.18

3.1

4.0

—

General examination and investigation of persons without complaint and reported diagnosis

336

1221

1.43

8.18

4.0

3.7

—

Vascular disorders of the intestines

304

2.20

8.15

3.3

3.7

—

Injuries to unspecified part of trunk, limb or body region

424

2.00

8.15

4.0

3.9

—

Fracture at wrist and hand level

215

1406

1.53

8.12

4.0

3.9

—

Idiopathic gout

468

1.94

8.04

3.4

3.8

—

Dilated cardiomyopathy

104

567

1.85

8.03

3.5

3.7

—

Other general symptoms and signs

129

2.87

8.02

3.7

3.5

—

Biomechanical lesions, not elsewhere classified

206

2.46

8.01

3.1

4.1

—

Other or unspecified immunodeficiency

11.77

7.99

9.7

5.1

—

Follicular cysts of skin and subcutaneous tissue

128

743

1.73

7.97

4.5

3.8

—

Diseases of pulp and periapical tissues and dental caries

446

1688

1.36

7.96

3.7

3.8

—

Coxibs

188

614

1.61

7.94

3.5

4.5

—

Scleritis and episcleritis

201

2.46

7.91

3.3

3.8

—

Tuberculosis of other organs, strict

100

3.17

7.89

5.7

3.5

—

Type 2 diabetes, definitions combined

601

2706

1.29

7.88

3.5

4.0

—

Insulin medication

412

2529

1.35

7.86

3.5

3.9

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

13.20

7.81

4.5

3.0

—

Type 2 diabetes, definitions combined, including avohilmo

600

2688

1.29

7.79

3.5

4.0

—

Temporal arteritis

162

2.64

7.74

3.9

3.5

—

Gonarthrosis [arthrosis of knee](FG)

478

2068

1.33

7.73

3.4

3.8

—

Selective deficiency of immunoglobulin G [IgG] subclasses

8.45

7.72

5.0

4.3

—

Panic disorder

384

2.02

7.72

3.9

4.2

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

134

2.82

7.70

3.5

—

Disorders resulting from impaired renal tubular function

151

2.70

7.68

3.3

4.3

—

Tuberculosis of other organs, strict, including avohilmo

102

3.11

7.64

5.7

3.5

—

Other disorders of bone

117

671

1.75

7.62

3.5

3.9

—

Nonsuppurative otitis media, including avohilmo

165

890

1.61

7.62

4.2

4.1

—

Other congenital malformations, not elsewhere classified

10.39

7.60

8.9

2.6

—

Radiculopathy

120

694

1.74

7.60

3.5

3.8

—

Autoimmune hepatitis, wide definition

175

2.55

7.60

3.0

4.2

—

Heart failure and hypertrophic cardiomyopathy

3.31

7.60

3.2

3.6

—

Other disorders of kidney and ureter

105

585

1.81

7.57

3.6

3.7

—

Tumor necrosis factor alpha inhibitors

506

1.87

7.55

3.9

4.2

—

Episcleritis

158

2.62

7.54

3.3

3.8

—

Other/unspecified reactive arthropathies

237

2.30

7.52

4.7

3.9

—

Disorders of choroid and retina

561

3046

1.29

7.50

3.8

—

Discitis, unspecified

3.62

7.48

3.0

4.2

—

Injuries to the elbow and forearm

438

2827

1.33

7.47

4.0

—

Caries of enamel

574

2919

1.29

7.45

4.1

3.9

—

Multiple myeloma, including Hilmo

189

2.47

7.44

2.8

4.0

—

Other disorders involving the immune mechanism, not elsewhere classified

109

2.99

7.42

5.1

4.4

—

Superficial injury of lower leg

162

1019

1.60

7.42

3.5

4.0

—

Hypoparathyroidism

154

2.64

7.41

4.0

3.6

—

Type 2 diabetes, strict (exclude DM1)

602

2736

1.28

7.39

3.5

4.0

—

Pyogenic arthritis

284

2.17

7.38

3.5

4.2

—

Hypokalaemia

489

1.87

7.37

3.4

3.8

—

Stroke, excluding SAH

441

2398

1.33

7.35

3.5

3.7

—

Other specified and unspecified personality disorders

252

2.24

7.35

3.6

4.3

—

Use of donepezil

1203

0.50

7.34

3.9

3.5

—

Other specified/unspecified necrotizing vasculopathies

3.94

7.32

4.8

4.1

—

Unspecific neurodegenerative disorder

184

1913

0.66

7.32

3.4

3.6

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

192

1242

1.53

7.32

3.7

4.2

—

Other orthopaedic follow-up care

197

2.41

7.27

3.8

4.0

—

SLE, ICD10

116

2.89

7.25

2.7

3.5

—

SLE, strict definition

116

2.89

7.25

2.7

3.5

—

Unstable angina pectoris

271

1489

1.44

7.24

3.5

3.7

—

Other embolism and thrombosis

550

1.81

7.23

3.7

—

Giant cell arteritis

192

2.44

7.22

3.8

3.5

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

161

546

1.63

7.17

3.4

4.1

—

Mental and behavioural disorders due to cannabinoids

3.97

7.17

2.3

3.7

—

Rash and other nonspecific skin eruption

348

2.03

7.14

3.8

4.0

—

Calcific aortic valvular stenosis, including rheumatic fever

245

1631

1.45

7.13

3.3

3.6

—

Coxarthrosis [arthrosis of hip](FG)

373

1893

1.36

7.12

3.5

3.7

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

101

3.02

7.11

5.3

4.3

—

Respiratory conditions due to other external agents

3.10

7.11

2.9

3.8

—

Other diseases of pancreas

397

1.96

7.10

3.9

—

Benign neoplasm of mouth and pharynx

460

1.89

7.10

4.4

3.8

—

Calcific aortic valvular stenosis, diagnosis (helper)

244

1627

1.45

7.09

3.3

3.6

—

Operations 2 for CAVS

244

1627

1.45

7.09

3.3

3.6

—

Superficial injury of head

163

1038

1.58

7.08

3.4

3.9

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

588

2734

1.28

7.07

3.5

4.1

—

Non-follicular lymphoma

461

1.88

7.07

3.2

3.7

—

Other disorders of ear

597

3035

1.27

7.06

4.3

3.8

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

147

915

1.61

7.05

3.9

4.1

—

Calcific aortic valvular stenosis, operated

244

1629

1.45

7.05

3.3

3.6

—

Calcific aortic valvular stenosis

244

1629

1.45

7.05

3.3

3.6

—

Faecal incontinence

343

2.03

7.04

3.8

3.9

—

Urticaria

164

1048

1.57

7.04

4.7

3.9

—

Arterial embolism and thrombosis

257

2.20

7.04

2.7

3.4

—

Nonsuppurative otitis media

120

612

1.71

7.02

4.2

4.4

—

Fenamates

360

1.84

7.01

3.6

4.2

—

Reactive arthropathies

317

2.07

6.99

4.6

4.1

—

Other and unspecified psoriasis

271

2.16

6.98

3.4

3.8

—

Peripheral arterial reconstruction

147

919

1.61

6.97

3.3

3.6

—

Glomerulonephritis

400

1.94

6.95

3.6

3.8

—

Ocular pain

278

2.14

6.94

5.5

3.8

—

Fracture of foot, except ankle

144

896

1.61

6.94

3.7

4.0

—

Diseases of tongue

189

2.40

6.93

3.8

4.2

—

Psoriasis

183

1204

1.53

6.92

3.3

3.7

—

Gangrene, not elsewhere classified

6.98

6.91

3.0

3.3

—

Disorder of external ear, unspecified

125

2.76

6.89

3.9

3.6

—

Transient ischemic attack

388

2314

1.34

6.89

3.4

3.7

—

Collagenous colitis

360

1.99

6.87

4.4

3.8

—

Inguinal hernia

385

1906

1.35

6.87

3.7

—

Polyarteritis nodosa and related conditions

3.88

6.86

4.7

3.7

—

Purpura and other haemorrhagic conditions

102

581

1.77

6.86

3.5

3.8

—

Behavioural syndromes associated with physiological disturbances and physical factors

569

3027

1.27

6.83

3.6

4.0

—

Diabetes, insulin treatment (Kela reimbursement)

642

3044

1.26

6.76

3.5

4.0

—

Giant cell arteritis with polymyalgia rheumatica

174

2.46

6.73

3.9

3.6

—

Assault

384

1.94

6.69

4.6

—

Polyarthrosis

144

812

1.60

6.67

3.8

—

Malignant neoplasm of heart, mediastinum and pleura

4.11

6.67

2.4

4.0

—

Other hammer toe(s) (acquired)

123

674

1.67

6.66

3.7

3.9

—

Other and unspecified visual disturbances

406

1.91

6.66

3.2

3.9

—

Cardiac murmurs and other cardiac sounds

166

2.45

6.65

4.7

4.2

—

Benign neoplasm: Small intestine

175

2.44

6.64

5.5

3.5

—

Psoriatic and enteropathic arthropathies

393

1.92

6.60

3.5

3.7

—

Hypertension, Pulmonary Arterial

5.53

6.56

3.4

3.5

—

Other or unspecified ileus, impaction or obstruction

133

824

1.62

6.55

4.3

3.6

—

Otitis externa

142

894

1.60

6.55

3.4

3.8

—

Acute pancreatitis

141

888

1.60

6.51

3.5

3.6

—

Other and unspecified disorders of vitreous body

289

2050

1.38

6.50

4.1

3.8

—

Sequelae of other external causes

214

2.27

6.50

3.5

3.9

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

183

2.39

6.50

3.0

4.0

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

12.29

6.49

3.8

3.3

—

Barrett oesophagus

208

2.29

6.49

3.6

4.1

—

Disorders of tooth development and eruption

387

1.84

6.48

4.8

4.1

—

Peripheral artery operations in Hilmo

107

630

1.71

6.43

3.7

3.6

—

Other diseases of arteries and capillaries

369

1.94

6.43

3.6

3.5

—

Glomerular disorders in diseases classified elsewhere

512

1.79

6.43

5.0

3.5

—

Fall on and from stairs and steps

171

1128

1.52

6.42

3.8

3.6

—

Other and unspecified tonsillitis

140

728

1.60

6.42

3.7

4.0

—

Hallux valgus (acquired)

202

976

1.48

6.41

3.1

3.8

—

Benign neoplasm of middle ear and respiratory system

349

1.97

6.40

5.1

3.9

—

Myelodysplastic syndrome

3.68

6.37

3.0

3.9

—

Myocardial infarction, strict

316

1641

1.37

6.34

3.3

3.7

—

Pain and other conditions associated with female genital organs and menstrual cycle

450

1.77

6.33

4.2

4.4

—

Haemolytic anaemias

131

2.64

6.33

3.0

3.8

—

Right bundle-branch block

131

2.63

6.32

3.4

4.1

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

407

2438

1.31

6.31

3.6

3.8

—

Benign neoplasm: Transverse colon

530

1.77

6.31

3.8

3.7

—

Persistent mood disorders

116

702

1.66

6.29

4.1

3.8

—

Systemic lupus erythematosus, unspecified

103

2.86

6.29

2.4

3.5

—

Congenital malformations, deformations and chromosomal abnormalities

304

2117

1.36

6.29

3.9

4.1

—

Postmenopausal osteoporosis with pathological fracture

263

2.11

6.29

4.3

3.5

—

Fracture of lower leg, including ankle

339

2489

1.34

6.28

3.5

3.9

—

Hypoplasia of dental enamel

18.34

6.27

17.0

3.2

—

Infections with a predominantly sexual mode of transmission, including avohilmo

173

1049

1.51

6.26

4.0

4.5

—

Viral warts

331

1.98

6.24

4.0

3.9

—

Myelodysplastic syndrome, including Hilmo

132

2.62

6.24

3.7

3.9

—

Specific personality disorders

116

704

1.65

6.22

3.5

4.2

—

Anosmia

3.87

6.19

3.1

3.9

—

Special screening examination for neoplasms

238

2.16

6.19

4.2

3.3

—

Rheumatism, unspecified

460

1.82

6.17

4.1

3.8

—

Hypersensitivity angiitis

7.12

6.17

3.6

4.0

—

Migraine

241

1325

1.42

6.13

4.0

4.2

—

Benign neoplasm: Tongue

116

2.72

6.12

4.4

3.9

—

Fall on same level involving ice and snow

365

2773

1.32

6.08

3.6

3.9

—

Inguinal hernia, bilateral

492

1.78

6.07

3.7

3.8

—

Diseases of the ear and mastoid process

679

2755

1.24

6.07

4.4

3.8

—

Generalized anxiety disorder

404

1.86

6.06

4.7

4.6

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

195

2.27

6.06

3.5

4.1

—

Disorders of vitreous body

342

2454

1.33

5.98

4.1

3.7

—

Benign neoplasm: Rectum, anus and anal canal

148

963

1.55

5.97

3.6

—

Mouth breathing

241

1721

1.40

5.97

3.5

3.8

—

Keratitis

217

1524

1.43

5.96

4.3

3.8

—

Deforming dorsopathies

163

1083

1.51

5.94

4.0

—

Coxarthrosis

338

1631

1.34

5.93

3.5

3.7

—

Diabetes medication

630

2972

1.24

5.93

3.5

4.0

—

Other extrapyramidal and movement disorders in other diseases

167

1117

1.50

5.92

4.1

3.6

—

Other infective otitis externa

223

2.17

5.92

3.1

4.0

—

Abscess of anal and rectal regions

276

2.04

5.91

3.3

4.0

—

Molar incisor enamel hypoplasia, with caries

15.25

5.91

17.0

4.3

—

Fissure and fistula of anal and rectal regions

145

942

1.55

5.88

4.2

3.7

—

Mixed and other personality disorders

204

2.22

5.88

3.0

4.3

—

Disorders of vitreous body and globe

351

2520

1.32

5.87

4.1

3.7

—

Inguinal or femoral hernia, bilateral

505

1.76

5.85

3.7

3.8

—

Other aneurysm

244

2.11

5.85

3.2

3.3

—

Other/unspecified rheumatoid arthritis

520

1.74

5.84

4.1

3.6

—

Spondyloarthritis

111

678

1.64

5.84

3.5

3.6

—

Alcohol-induced chronic pancreatitis

271

2.05

5.84

3.2

4.1

—

Impetigo

113

2.68

5.83

6.8

3.6

—

Adalimumab

305

1.98

5.82

4.0

4.2

—

Ventral hernia

157

1041

1.51

5.81

3.9

3.6

—

Fibroblastic disorders

157

1041

1.51

5.81

3.6

3.7

—

Other joint disorders

480

1959

1.28

5.81

3.6

4.1

—

Acute pharyngitis

385

1.86

5.81

3.3

3.9

—

Insulin, combination of fast acting with intermediate-acting or long-acting

412

2902

1.29

5.79

3.5

3.8

—

Propionic acid derivatives

184

619

1.50

5.78

3.4

4.7

—

Lesion of lateral popliteal nerve

193

2.25

5.78

3.3

4.4

—

Acute pancreatitis (for exclusion)

141

915

1.55

5.77

3.5

3.6

—

Benign neoplasm: Ascending colon

110

674

1.64

5.75

4.0

3.7

—

Sleep disorders

535

2942

1.25

5.75

3.6

4.1

—

Arthrosis

429

1819

1.29

5.74

3.4

3.8

—

Fracture of skull and facial bones

131

837

1.57

5.74

4.1

4.0

—

Other specified/unspecified hearing loss

406

1.84

5.73

3.5

—

Other and specified injuries of hip and thigh

2.88

5.71

6.2

3.6

—

Olecranon bursitis

260

2.06

5.70

4.1

—

Agranulocytosis

443

1.80

5.69

3.2

4.0

—

Other local infections of skin and subcutaneous tissue

422

1.81

5.66

3.6

3.8

—

Failure and rejection of transplanted organs and tissues

3.62

5.65

4.5

3.8

—

Fibrosis and cirrhosis of liver

351

1.90

5.64

4.5

3.9

—

Alzheimer disease, including avohilmo

167

1692

0.68

5.64

3.3

3.6

—

Rare circulating lymphoid malignancy, including Hilmo

104

2.73

5.62

3.7

4.5

—

Idiopathic thrombocytopenic purpura

110

2.68

5.60

4.3

4.0

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

337

2333

1.32

5.58

3.9

4.0

—

Intestinal stricture

216

1536

1.41

5.57

3.9

3.6

—

Diseases of spleen

3.05

5.57

2.4

3.8

—

Use of memantine

114

1444

0.63

5.57

3.2

3.5

—

Use of other anti-dementia drugs

114

1444

0.63

5.57

3.2

3.5

—

Other skin changes

140

917

1.53

5.52

4.4

3.6

—

Melanocytic naevi

178

1224

1.46

5.52

3.9

3.8

—

Infections with a predominantly sexual mode of transmission

138

899

1.54

5.49

4.2

—

Viral and other specified intestinal infections, including avohilmo

134

837

1.54

5.45

4.9

4.2

—

Disorders of mineral metabolism

334

1.90

5.44

4.5

3.8

—

Other renal tubulo-interstitial diseases

2.99

5.44

7.1

3.8

—

Other and unspecified local infections of skin and subcutaneous tissue

392

1.82

5.40

3.7

3.8

—

Abnormal findings in nipple discharge synovial fluid wound secretions

3.47

5.34

4.9

4.2

—

Diseases of external ear

227

1641

1.39

5.34

3.9

3.8

—

Calculus of kidney and ureter

205

1457

1.41

5.33

3.3

3.7

—

Acute bronchiolitis

2.78

5.33

8.9

4.3

—

Arthropathies

489

1960

1.26

5.32

3.7

4.1

—

Molar incisor enamel hypoplasia

3.75

5.32

11.2

4.6

—

ILD and respiratory illness in diseases classified elsewhere

6.25

5.32

3.2

4.4

—

Alcohol abuse, main dg, excluding more controls

497

1.72

5.31

4.1

4.0

—

Trigger finger

551

1.68

5.27

3.7

3.8

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

101

621

1.64

5.24

2.9

3.8

—

Malignant immunoproliferative diseases

3.59

5.24

5.2

4.5

—

Pedestrian injured in transport accident

255

2.02

5.23

4.5

4.0

—

Pneumoconiosis due to asbestos and other mineral fibres

2.73

5.21

3.7

3.4

—

Tobacco use

189

2.19

5.20

3.0

4.3

—

Other diseases of liver

116

739

1.58

5.20

3.3

3.7

—

Dementia

204

1940

0.72

5.18

3.3

3.7

—

Acute suppurative otitis media

112

658

1.59

5.17

5.5

4.6

—

Other and unspecified diseases of blood and blood-forming organs

109

2.61

5.16

3.0

3.9

—

Benign neoplasm: Rectum

132

868

1.53

5.15

3.7

3.6

—

Hyperkalaemia

250

2.02

5.14

3.9

3.7

—

Helminthiases, including avohilmo

109

2.59

5.14

3.3

3.9

—

Insomnia

511

2865

1.24

5.12

3.5

4.1

—

Acute alcohol intoxication

160

1095

1.47

5.12

3.7

3.8

—

Mixed conductive and sensorineural hearing loss

557

1.66

5.09

3.4

—

Amputation of toe

357

1.84

5.07

3.9

3.6

—

Other retinal disorders

444

2684

1.26

5.07

3.7

3.8

—

Other arterial embolism and thrombosis

110

2.58

5.07

2.8

3.7

—

Adult respiratory distress syndrome

3.49

5.07

2.7

4.1

—

Melanocytic naevi of trunk

467

1.72

5.06

3.6

3.8

—

Mental disorders, not otherwise specified

218

2.08

5.03

3.5

4.1

—

Anaemia in chronic diseases classified elsewhere

2.67

5.01

3.1

4.0

—

Abnormal blood-pressure reading, without diagnosis

2.71

5.01

3.2

—

Carcinoma in situ of skin of upper limb, including shoulder

129

2.45

5.01

5.1

3.8

—

6.35

5.00

3.4

4.2

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

160

1101

1.46

5.00

3.3

3.7

—

Sleep disorders, other/unspecified

2.65

4.99

4.6

4.0

—

Dementia, including avohilmo

221

2057

0.73

4.99

3.3

3.7

—

Mesothelioma

3.77

4.97

2.3

4.1

—

Diseases of middle ear and mastoid

301

1869

1.32

4.96

4.4

3.9

—

Attention to artificial openings

167

2.24

4.96

3.6

3.9

—

Drug-induced cataract

2.71

4.94

6.4

3.9

—

Hypoplasia of dental enamel , including avohilmo

3.72

4.94

11.7

4.2

—

Obesity due to excess calories

252

1877

1.35

4.94

3.3

4.0

—

Inflammatory bowel disease

177

1244

1.43

4.93

3.6

3.9

—

Disorders of orbit

142

2.35

4.93

3.3

3.4

—

Exclusions for E4_PCOS_CONSORTIUM

364

1764

1.29

4.93

4.0

—

Mucosal proctocolitis

427

1.74

4.89

3.5

3.9

—

Systemic sclerosis (FG)

2.74

4.87

4.4

3.6

—

Acquired haemolytic anaemia

2.68

4.85

2.7

3.9

—

Other specified and unspecified disorders of eye and adnexa

137

2.36

4.84

4.5

3.8

—

Injury of unspecified body region

312

1.87

4.84

4.3

3.9

—

Other diseases of blood and blood-forming organs

298

1.90

4.84

4.3

3.8

—

Open wound of forearm

392

1.77

4.82

3.2

3.7

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

422

1.74

4.81

3.6

3.7

—

Other metabolic disorders

422

1.74

4.80

3.7

3.9

—

Other/unspecified enthesopathies of lower limb, excluding foot

236

2.01

4.79

3.9

4.3

—

Other superficial mycoses

2.92

4.78

3.5

3.6

—

Personal history of other diseases and conditions

276

1.92

4.78

3.7

4.1

—

Mesothelioma, including Hilmo

3.49

4.78

2.4

4.0

—

Migraine without aura

467

1.70

4.78

3.3

4.6

—

Cholelithiasis, broad definition with cholecystitis

543

2954

1.22

4.78

3.4

3.8

—

Pleural plaque without asbestos

190

2.14

4.76

3.9

3.5

—

Myocardial infarction, without ST-elevation

302

2092

1.31

4.75

3.4

3.6

—

Post-traumatic wound infection, not elsewhere classified

2.64

4.75

5.6

4.1

—

Phlebitis and thrombophlebitis (not including DVT)

141

958

1.48

4.73

4.2

3.6

—

Migraine with aura and triptan purchases

387

1.76

4.71

5.1

4.5

—

Disorders of muscles

373

1.78

4.70

4.1

3.8

—

Vascular diseases of the intestine

171

2.19

4.70

3.3

3.5

—

Diabetic nephropathy, excluding more controls

498

1.61

4.69

2.8

3.5

—

Psoriatic arthropathies

366

1.79

4.69

3.4

4.0

—

Carcinoma in situ of skin of trunk

172

2.19

4.66

4.2

3.7

—

Small cell lung cancer, including Hilmo

103

2.56

4.65

3.2

3.4

—

Small cell lung cancer

103

2.56

4.65

3.2

3.4

—

Acute laryngitis and tracheitis

262

1.92

4.64

4.6

3.6

—

Abnormal spermatozoa

653

0.46

4.63

3.3

3.6

—

Other coagulation defects

260

1.94

4.63

3.1

3.6

—

Dialysis

140

2.31

4.63

3.7

4.4

—

Allergic urticaria

253

1.95

4.63

4.0

3.6

—

Selective deficiency of immunoglobulin A [IgA]y

8.57

4.62

4.9

3.3

—

Thrombocytopenia, unspecified

303

1.86

4.61

3.8

—

Diffuse large B-cell lymphoma, helper endpoint

199

2.08

4.61

3.6

3.9

—

Diffuse large B-cell lymphoma

199

2.08

4.61

3.6

3.9

—

Diffuse large B-cell lymphoma, including Hilmo

199

2.08

4.61

3.6

3.9

—

Elevated blood glucose level

332

1.82

4.60

3.4

3.7

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

254

1.95

4.59

3.8

3.9

—

Systemic sclerosis

2.65

4.59

4.4

3.4

—

Urolithiasis

218

1609

1.36

4.58

3.3

3.6

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

4.59

4.58

6.1

5.4

—

Cardiac arrest

173

2.07

4.57

3.8

3.7

—

Hernia of abdominal wall

293

2258

1.30

4.56

3.8

3.7

—

Amputation

482

1.67

4.55

3.7

3.4

—

Toxic liver disease

3.11

4.55

3.6

4.1

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

7.05

4.55

2.5

3.1

—

Osteonecrosis due to drugs

2.93

4.54

3.3

4.1

—

Alcohol withdrawal state with delirium

298

1.86

4.52

3.4

4.0

—

Benign thyroid growths and nodules

207

1409

1.37

4.52

3.4

3.9

—

Event of undetermined intent

214

2.02

4.51

4.9

4.0

—

Malignant neoplasm of digestive organs, including Hilmo

264

1469

1.32

4.49

3.7

3.8

—

Suppurative and unspecified otitis media

165

1030

1.42

4.48

5.0

4.3

—

Meniscus derangement

331

1711

1.29

4.47

3.6

3.8

—

Polymyalgia rheumatica

632

1.58

4.47

3.1

3.5

—

Bacterial, viral and other infectious agents

299

1.85

4.47

5.7

4.1

—

Other obstetric conditions, not elsewhere classified

323

1.66

4.45

3.6

4.5

—

Ulcerative colitis

137

938

1.47

4.44

3.5

3.9

—

Thoracic aortic aneurysm

106

689

1.55

4.43

3.6

3.5

—

Mixed connective tissue disease

3.05

4.42

5.2

4.0

—

Other enthesopathies

165

1170

1.41

4.42

3.9

—

Other maltreatment syndromes

2.64

4.41

4.5

3.8

—

Osteomyelitis

265

1.90

4.40

3.7

—

Inflammatory diseases of the central nervous system

315

1.82

4.40

4.3

3.7

—

Bacterial, viral and other infectious agents, including avohilmo

315

1.82

4.40

6.4

4.1

—

Hypertensive Renal Disease

163

2.17

4.39

2.9

3.4

—

Other keratitis

404

1.72

4.37

4.6

4.0

—

Adhesive capsulitis of shoulder

103

667

1.55

4.37

3.6

3.7

—

KRA_PSY_EATING, excluding more controls

105

2.46

4.36

3.0

5.5

—

Abrasion of teeth

208

1537

1.36

4.36

3.8

3.9

—

Biguanides

589

2957

1.20

4.33

3.2

3.9

—

Gonarthrosis

386

1733

1.26

4.33

3.3

3.8

—

Benign neoplasm: Stomach

421

1.70

4.32

3.5

3.8

—

Cirrhosis of liver, NAS

253

1.92

4.31

3.8

3.9

—

Valvular operations

551

1.60

4.31

3.7

—

Other peripheral vascular diseases

303

1.83

4.30

3.4

3.6

—

Emotionally unstable personality disorder

274

1.87

4.30

3.1

4.2

—

Umbilical hernia

162

1153

1.41

4.28

3.6

3.7

—

Corticotropin deficiency

4.26

6.1

4.0

—

Other and unspecified glaucoma

363

1.75

4.26

4.1

3.8

—

Entropion and trichiasis of eyelid

423

1.69

4.25

3.4

3.5

—

Other (seronegative) rheumatoid arthritis, wide

123

833

1.48

4.24

4.0

3.6

—

Systemic sclerosis, icd10

2.54

4.24

4.4

3.4

—

Symptoms and signs involving emotional state

2.58

4.23

8.0

4.3

—

Hypertrophic cardiomyopathy

179

2.09

4.23

3.5

4.1

—

Multiple myeloma and malignant plasma cell neoplasms

234

1.95

4.22

2.8

3.8

—

Alzheimer’s disease (Atypical or mixed)

661

0.49

4.22

3.6

—

Carcinoma in situ of skin of scalp and neck

160

2.16

4.19

4.5

3.5

—

Disorders of continuity of bone

335

1.77

4.18

5.0

4.0

—

Pruritus

402

1.70

4.18

2.8

3.7

—

Disorders of calcium metabolism

249

1.90

4.16

3.0

3.9

—

Morphin

2.56

4.15

5.5

4.2

—

Diplopia

549

1.59

4.15

4.1

3.8

—

Misadventures to patients during surgical and medical care

604

1.56

4.15

4.1

3.8

—

Other/unspecified synovitis and tenosynovitis

403

1.70

4.15

3.6

3.8

—

Metatarsalgia

314

1.79

4.14

3.8

4.1

—

Superficial injury of ankle and foot

396

1.70

4.12

4.0

4.3

—

Malignant neoplasm of thymus

8.43

4.12

3.8

3.1

—

Infection of intervertebral disc (pyogenic)

3.14

4.11

4.7

4.1

—

Mantle cell lymphoma, including Hilmo

3.14

4.11

3.1

4.2

—

Pacemaker

270

1940

1.30

4.11

3.4

3.6

—

Other disorders of the genitourinary system

504

1.62

4.10

3.3

3.6

—

Alcohol-induced acute pancreatitis

148

2.19

4.10

3.3

4.7

—

Other disorders of conjunctiva

614

1.56

4.10

3.6

3.7

—

Other neurotic disorders

175

2.08

4.06

3.4

4.5

—

Hypersensitivity pneumonitis due to organic dust

2.81

4.05

4.7

4.2

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

307

1.64

4.04

3.7

4.6

—

Shigellosis, including avohilmo

5.16

4.04

3.0

3.5

—

Other and unspecified urticaria

102

672

1.52

4.03

4.0

—

Benign neoplasm of breast

384

1.70

4.02

3.8

3.6

—

Etanercept

203

1.98

4.02

4.0

3.6

—

Spondylopathies (FG)

438

1.65

3.99

3.8

3.9

—

Benign neoplasm: Adrenal gland

333

1.76

3.99

3.6

3.8

—

Chalazion

423

1.66

3.99

3.5

3.9

—

Eosinophilia

2.87

3.99

3.9

—

Malignant neoplasm of bladder, including Hilmo

532

1.59

3.98

3.7

3.8

—

Open wound of abdomen, lower back and pelvis

2.50

3.97

4.0

3.8

—

Artrosis, including avohilmo

489

2204

1.22

3.97

3.5

3.9

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

4.21

3.95

6.0

4.1

—

Nephrotic syndrome

112

2.35

3.94

3.6

4.6

—

Postmenopausal bleeding

151

554

1.43

3.93

3.8

3.9

—

Malignant neoplasm of mesothelium and soft tissue

164

2.10

3.93

3.6

4.0

—

Eating disorders

211

1.95

3.93

4.0

4.2

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

151

2.14

3.91

4.5

3.6

—

Disorders of plasma-protein metabolism, not elsewhere classified

4.94

3.91

3.1

2.5

—

Traumatic subarachnoid haemorrhage

145

2.16

3.88

3.8

4.4

—

Exposure to other and unspecified inanimate mechanical forces

270

1.83

3.86

4.7

4.2

—

Other specified/unspecified dorsopathies

113

2.32

3.86

2.9

4.4

—

Other (not insulin) diabetes medications

588

2903

1.19

3.85

3.4

3.9

—

Hordeolum and other deep inflammation of eyelid

200

1.96

3.82

5.2

4.1

—

Intestinal malabsorption

166

2.07

3.81

7.7

4.3

—

Hypermobility syndrome

101

2.39

3.81

3.7

3.5

—

Foreign body in respiratory tract

166

2.06

3.81

3.6

4.3

—

Superficial injury of hip and thigh

103

689

1.50

3.81

3.0

3.6

—

Localized swelling, mass and lump of skin and subcutaneous tissue

187

1392

1.35

3.80

4.3

3.8

—

Other specified/unspecified inflammatory spondylopathies

114

2.30

3.78

3.4

3.6

—

Open wound of wrist and hand

248

1857

1.29

3.75

4.2

3.9

—

Neuroendocrine tumor and carcinoma of lung

3.94

3.74

3.5

4.6

—

Malignant neoplasm of thymus, including Hilmo

6.95

3.72

3.8

4.8

—

Oesophageal varices

175

2.02

3.70

6.0

4.1

—

115

2.27

3.70

4.3

4.7

—

Oesophageal obstruction

155

2.09

3.68

4.2

—

Monoamine oxidase A inhibitors

425

1.63

3.68

3.4

3.9

—

Palmar fascial fibromatosis [Dupuytren]

107

728

1.48

3.67

3.8

3.6

—

Assault by bodily force

210

1.91

3.67

4.3

4.0

—

Status post-ami

178

998

1.36

3.66

3.1

3.6

—

Atypical facial pain

176

2.00

3.64

3.7

3.8

—

Other and/or unspecified nontoxic goitre

320

1.73

3.64

3.2

3.8

—

Exposure to other and unspecified animate mechanical forces

2.55

3.64

4.8

4.0

—

Other congenital malformations

232

1.86

3.63

6.3

4.5

—

Fracture of forearm

313

2250

1.25

3.62

4.2

3.9

—

Other benign neoplasms of skin

233

1803

1.30

3.62

4.2

3.7

—

Other disorders of Eustachian tube

104

2.33

3.61

4.0

3.6

—

Other or unspecified common variable immunodeficiency

8.16

3.61

6.7

2.9

—

Open wound of ankle and foot

389

1.65

3.60

4.1

3.8

—

Otitis externa, unspecified

389

1.65

3.60

3.5

4.0

—

Superficial injury of wrist and hand

107

731

1.47

3.59

4.5

4.0

—

Macular pucker

116

806

1.45

3.58

3.6

3.5

—

Other mycoses, not elsewhere classified/unspecified, including avohilmo

2.69

3.58

4.4

4.1

—

Cholelithiasis

509

2913

1.19

3.58

3.4

3.8

—

Cluster headache, strict

2.41

3.56

3.1

4.5

—

Maternal care for other conditions predominantly related to pregnancy

402

1.63

3.56

3.3

4.2

—

Other and unspecified aplastic anaemias

3.11

3.56

3.1

4.1

—

Allergic contact dermatitis

429

1.61

3.55

5.3

3.9

—

Amiodarone users

508

1.57

3.55

3.5

3.8

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

189

1426

1.33

3.54

4.0

3.8

—

ILD medications: acetylcysteine

4.33

3.53

3.7

2.6

—

Haemorrhoids and perianal venous thrombosis

203

1536

1.32

3.53

3.4

3.8

—

Diseases of male genital organs

325

1307

1.25

3.52

4.2

3.8

—

Nonischemic cardiomyopathy

430

1.61

3.52

3.7

3.8

—

Seborrhoeic keratosis

168

1247

1.35

3.52

3.9

3.6

—

Hypopituitarism

242

1.83

3.52

3.8

3.9

—

Other/unspecified enthesopathies, not elsewhere classified

331

1.70

3.51

3.5

3.9

—

Achalasia of cardia

2.74

3.51

2.7

4.8

—

Chondropathies

541

1.54

3.50

3.8

4.0

—

Thyrotoxicosis

140

1010

1.39

3.50

4.0

3.8

—

Alzheimer’s disease (Early onset)

211

0.28

3.49

3.3

3.5

—

L04AC Interleukin inhibitors

200

1.91

3.48

4.1

4.3

—

Fracture of shoulder and upper arm

220

1698

1.30

3.46

4.0

3.9

—

Epilepsy

172

1280

1.34

3.46

3.4

3.9

—

Extreme obesity with alveolar hypoventilation

159

2.03

3.46

3.8

4.2

—

Enthesopathies of lower limb, excluding foot

123

871

1.42

3.43

3.9

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

100

1256

0.69

3.43

3.6

4.0

—

Other hearing loss

209

1556

1.30

3.43

3.4

3.6

—

Other enthesopathy of foot (+metatarsalgia)

341

1.68

3.42

3.8

4.0

—

Disorders of refraction and accommodation

138

993

1.39

3.42

3.8

4.0

—

Oxicams

141

572

1.40

3.42

3.5

4.1

—

Pleural plaque with presence of asbestos

380

1.65

3.42

3.5

—

Cerebral palsy and other paralytic syndromes

426

1.60

3.41

3.9

3.8

—

Extrapyramidal and movement disorders

255

2013

1.27

3.41

4.2

3.7

—

Other congenital malformations, including avohilmo

380

1.64

3.39

5.3

4.5

—

Arthropathies in other diseases classified elsewhere

140

2.09

3.39

3.4

4.2

—

Alzheimer disease

158

1517

0.74

3.38

3.2

3.6

—

Left bundle-branch block

275

1.76

3.37

3.3

3.9

—

Golimumab

101

2.30

3.37

4.7

3.8

—

Iridocyclitis

127

908

1.40

3.36

3.0

3.7

—

Drug-induced Cushing's syndrome

9.57

3.36

2.8

3.4

—

Use of rivastigmine

906

0.61

3.36

3.1

3.5

—

Other sleep disorders

397

1.62

3.35

3.8

3.9

—

Other diseases of stomach and duodenum

261

1.78

3.35

3.8

4.0

—

Charcot foot

2.75

3.34

2.9

3.8

—

Orthopaedic devices associated with adverse incidents

0.00

3.33

0.0

3.8

—

Premature rupture of membranes

337

0.46

3.33

2.6

4.2

—

Insulin, fast-acting

209

1613

1.30

3.33

3.9

3.8

—

Other salmonella infections, including avohilmo

141

2.07

3.32

3.2

3.4

—

Blepharochalasis

185

1406

1.32

3.32

3.5

3.7

—

Viral agents as the cause of diseases classified to other chapters

2.50

3.31

4.9

4.0

—

Oral lichen planus

102

2.28

3.31

4.1

3.9

—

Polyarthritis, unspecified

128

2.13

3.30

3.4

4.6

—

Anti-inflammatory and antirheumatic products, non-steroids

167

619

1.36

3.30

3.6

4.7

—

Pneumonia due to Haemophilus influenzae

8.85

3.29

3.7

2.3

—

Gout due to impairment of renal function

2.85

3.29

3.8

3.7

—

Benign neoplasm: Caecum

518

1.53

3.28

3.9

3.6

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

2.31

3.27

4.2

3.4

—

Arthropathic psoriasis

431

1.59

3.27

3.4

3.9

—

Other and unspecified injuries of head

323

1.68

3.27

3.6

4.1

—

Diabetic neuropathy

524

1.53

3.26

3.0

3.5

—

Cardiomyopathy, Hypertrophic obstructive

2.70

3.24

3.8

3.7

—

Schizophrenia or delusion, excluding more controls

138

994

1.37

3.24

3.5

4.1

—

Carcinoma in situ of skin of ear and external auricular canal

2.55

3.24

3.2

3.9

—

Cluster headache, wide

103

2.25

3.23

3.2

4.4

—

Injury of other and unspecified intrathoracic organs

272

1.74

3.21

3.3

3.8

—

Malignant neoplasm of head and neck, including Hilmo

410

1.59

3.20

4.4

4.0

—

Other and unspecified mood [affective] disorders

171

1.94

3.18

4.9

4.1

—

Small cell lung cancer, helper endpoint

124

2.12

3.16

3.2

3.6

—

Acute myeloid leukaemia

3.01

3.15

4.0

4.3

—

Acute myeloid leukaemia, including Hilmo

3.01

3.15

4.0

4.3

—

Acute myeloid leukaemia, helper endpoint

3.01

3.15

4.0

4.3

—

Other psoriatic arthropathies

396

1.60

3.15

3.4

3.9

—

Postzoster neuralgia

2.51

3.15

4.1

3.9

—

Ovarian cyst

152

639

1.36

3.14

4.0

4.1

—

Bulimia nervosa (incl. atypical)

2.97

3.14

2.8

4.1

—

Polycystic ovarian syndrome, consortium definition

323

1504

1.23

3.14

4.3

3.9

—

Mantle cell lymphoma

3.51

3.13

2.6

4.3

—

Iron deficiency anaemia secondary to blood loss (chronic)

104

728

1.43

3.13

3.3

3.6

—

Implicit parasitic Sepsis, including avohilmo

4.13

3.12

3.4

5.1

—

Myeloid leukaemia

118

2.15

3.12

4.1

4.0

—

Pyoderma gangrenosum

3.76

3.12

2.5

3.4

—

Otitis media, unspecified

259

1.71

3.10

5.6

3.5

—

IgA nephropathy (IgA glomerulonephritis)

2.35

3.09

6.3

3.4

—

Degeneration of macula and posterior pole

350

2226

1.22

3.09

3.6

3.7

—

Scoliosis

253

1.75

3.08

4.0

4.2

—

Erosion of teeth , including avohilmo

128

932

1.38

3.07

4.8

4.1

—

Muscle strain

2.24

3.07

5.2

3.7

—

Disseminated intravascular coagulation [defibrination syndrome]

6.12

3.07

2.4

3.5

—

Bicipital tendinitis

188

1.88

3.06

3.0

4.2

—

Childhood allergy (age < 16)

153

1.89

3.06

5.4

7.6

—

Acute lymphadenitis

160

1.95

3.04

4.0

3.6

—

Neuromuscular dysfunction of bladder

361

1.62

3.04

4.0

3.6

—

Nontoxic goitre/thyroid nodule

172

1313

1.31

3.03

3.3

3.7

—

Acute gastritis

300

1.68

3.02

3.5

3.7

—

Other and unspecified nonorganic psychotic disorders

593

1.47

3.02

3.4

4.2

—

Chronic diseases of tonsils and adenoids

346

1795

1.22

3.01

3.7

3.8

—

Hepatomegaly and splenomegaly, not elsewhere classified

3.62

3.01

5.1

4.1

—

Colonic or urogenital fistula

153

1150

1.33

3.01

4.1

3.6

—

Contusion of toe(s) with damage to nail

3.61

3.01

3.6

4.0

—

Glaucoma suspect

145

1926

0.75

3.01

3.3

3.7

—

Maternal care for (suspected) damage to fetus from alcohol

10.34

3.00

2.8

2.0

—

Disorders of parathyroid gland

131

951

1.37

2.99

3.6

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

166

1264

1.32

2.98

3.5

3.9

—

Artificial opening status

256

1.73

2.98

3.7

3.9

—

Other abnormal immunological findings in serum

2.66

2.97

4.9

3.8

—

Degenerative diseases of the nervous system

181

1682

0.77

2.97

3.2

3.6

—

Small fibre neuropathy

134

2.04

2.97

3.6

4.5

—

Anorexia (incl.atypical)

127

2.06

2.96

4.7

4.5

—

Personal history of risk-factors, not elsewhere classified

3.29

2.95

3.3

4.2

—

Abdominal aortic aneurysm (AAA)

519

1.50

2.94

3.0

3.4

—

Microscopic polyangiitis

3.57

2.94

7.0

3.5

—

Dermatitis due to substances taken internally

184

1.86

2.92

7.5

3.4

—

Normal-pressure hydrocephalus

242

0.37

2.92

2.8

3.9

—

Relapsing polychondritis

7.05

2.91

3.5

3.4

—

Drug-induced systemic lupus erythematosus

4.21

2.91

2.7

4.4

—

!Aliquae complicationes praecoces traumatis

170

1.90

2.91

5.3

3.7

—

Early complications of trauma

170

1.90

2.91

5.3

3.7

—

Other obstructive and reflux uropathy

135

2.01

2.91

3.4

3.7

—

Retinal detachments and breaks

239

1914

1.25

2.90

3.8

3.6

—

Corneal ulcer

698

1.42

2.89

4.5

3.8

—

Multiple myeloma

122

2.07

2.88

2.7

3.4

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

122

2.07

2.88

2.7

3.4

—

Other and unspecified disorders of adult personality and behaviour

6.81

2.88

2.8

2.1

—

Diabetic retinopathy, strict definition

689

0.62

2.88

3.5

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

190

941

1.30

2.87

3.9

4.0

—

Malignant neoplasm of breast, including Hilmo

190

941

1.30

2.87

3.9

4.0

—

Psoriatic arthropathies, ICD10

406

1.56

2.87

3.4

3.9

—

Personal history of medical treatment

2.82

2.84

3.7

3.9

—

Progressive systemic sclerosis

4.61

2.83

5.1

5.0

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

4.60

2.83

3.4

5.2

—

Viral and other specified intestinal infections

611

1.44

2.82

4.9

4.2

—

Tinnitus

138

1033

1.34

2.82

4.6

3.6

—

Other salmonella infections

130

2.02

2.81

2.9

3.4

—

Perforation of oesophagus

4.05

2.81

3.4

4.7

—

Inflammatory disease of uterus

345

1.60

2.81

3.3

4.1

—

Conductive hearing loss, unspecified

322

1.62

2.81

4.2

3.5

—

Diphtheria

8.97

2.80

2.6

3.2

—

Myocardial infarction, with ST-elevation

125

923

1.36

2.80

3.4

3.6

—

Tongue abnormality

246

1.72

2.80

3.9

4.2

—

Diphtheria, including avohilmo

8.88

2.79

2.6

3.2

—

Malignant neoplasm of bladder

299

1.65

2.79

3.8

—

Otalgia

284

1.66

2.78

4.4

3.6

—

Other congenital malformations of integument, including avohilmo

5.24

2.77

3.4

2.9

—

Malignant neoplasm of oesophagus

104

2.14

2.76

5.3

4.6

—

Ganglion

102

730

1.40

2.76

3.9

—

conjunctival haemorrhage

348

1.59

2.73

4.0

3.9

—

Hyperkinetic disorders, excluding more controls

175

1.82

2.72

2.8

5.8

—

Abnormal involuntary movements

574

1.45

2.72

4.1

3.8

—

Osteopathy in diseases classified elsewhere

3.54

2.72

2.6

4.4

—

Alcohol abuse, main dg

591

1.44

2.71

4.1

3.7

—

Cardiomyopathies, Secondary/extrinsic

3.84

2.69

5.2

3.0

—

Disorders in reading

4.25

2.68

3.1

3.9

—

Acne, including avohilmo

377

1.50

2.68

4.2

5.0

—

Pedestrian injured in collision with pedal cycle

112

2.07

2.68

4.7

4.0

—

Malignant neoplasm of breast

185

929

1.29

2.68

3.9

—

Ascites

288

1.64

2.66

2.8

4.0

—

Anogenital herpesviral [herpes simplex] infection

154

1.89

2.65

4.9

4.0

—

Chronic conjunctivitis

2.14

2.65

4.1

4.0

—

malignant neoplasm of male genital organs, including Hilmo

181

845

1.29

2.64

3.3

3.9

—

Acquired absence of organs, not elsewhere classified

2.59

2.64

2.9

4.2

—

Insulin, fast-acting or short human

210

1677

1.25

2.63

3.9

3.7

—

Malignant neoplasm of oral cavity, including Hilmo

169

1.85

2.63

2.6

4.2

—

Pre-eclampsia

533

0.56

2.63

4.0

—

Abnormal findings on diagnostic imaging of central nervous system

113

2.05

2.61

3.3

3.8

—

Other acute skin changes due to ultraviolet radiation

127

1.99

2.61

3.5

4.3

—

Benign neoplasm of meninges

416

1.52

2.61

3.4

3.8

—

Implicit parasitic Sepsis

3.73

2.61

2.8

5.1

—

Malignant neoplasm of urinary organs, including Hilmo

489

1.48

2.61

3.2

3.9

—

Chronic drug-induced interstitial lung disorders

7.72

2.60

5.6

4.3

—

Moderate visual impairment, monocular

4.14

2.60

8.3

3.0

—

Malignant neoplasm of breast, HER2-negative

184

928

1.28

2.59

3.9

—

Ankylosing spondylitis

298

1.62

2.59

3.9

—

Other conditions related to polyarteritis nodosa

5.75

2.58

9.7

3.1

—

Disorder of mineral metabolism, other/unspecified

7.50

2.58

6.0

2.9

—

Inflammatory diseases of female pelvic organs

277

1555

1.22

2.58

4.0

—

Injury of muscle and tendon at forearm level

2.38

2.57

3.9

3.5

—

Superficial injury of abdomen, lower back and pelvis

606

1.42

2.57

3.3

3.9

—

Panniculitis, unspecified

2.91

2.57

2.6

2.8

—

Somnolence, stupor and coma

149

1.89

2.56

5.3

4.3

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

236

1899

1.23

2.56

4.0

3.9

—

Malignant neoplasm of head and neck

346

1.57

2.56

4.9

3.8

—

Short stature, not elsewhere classified

4.66

2.56

11.0

12.1

—

Varicella [chickenpox], including avohilmo

149

1.89

2.55

3.0

4.1

—

Carcinoma in situ of other and unspecified digestive organs

193

1.78

2.55

3.7

4.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

342

2879

1.19

2.55

3.5

3.9

—

Other/unspecified crystal arthropathies

3.32

2.55

2.2

4.2

—

Pregnancy hypertension

1107

0.72

2.54

3.8

4.1

—

Myeloproliferative diseases

363

1.55

2.53

4.8

3.7

—

Acute peritonitis

269

1.65

2.53

3.3

3.7

—

L01XX Other antineoplastic agents

277

1.64

2.53

4.0

—

Insulin, intermediate and long-acting

338

2745

1.19

2.52

3.6

3.8

—

Acute and subacute iridocyclitis

102

743

1.38

2.52

3.0

3.7

—

Procreative management

142

892

1.31

2.51

5.5

4.4

—

Benign neoplasm: Larynx

129

1.96

2.51

6.6

4.3

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

2.13

2.50

3.1

4.5

—

Other mycoses, not elsewhere classified/unspecified

3.97

2.50

5.0

4.9

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

4.50

2.50

4.0

2.9

—

Cushing syndrome

2.71

2.47

2.6

4.2

—

Other specified/unspecified soft tissue disorders

173

1.80

2.46

2.9

3.4

—

Generalized skin eruption due to drugs and medicaments

137

1.91

2.46

8.8

3.6

—

Disease of hard tissues of teeth, NOS

289

1248

1.21

2.46

3.4

3.7

—

Viral agents as the cause of diseases classified to other chapters, including avohilmo

2.16

2.46

4.9

3.8

—

Atopic conjunctivitis

123

1.96

2.45

3.0

3.6

—

Diabetic maculopathy

504

0.58

2.45

3.6

3.4

—

Anterior Iridocyclitis

109

807

1.35

2.44

3.0

3.6

—

Arterial embolism and thrombosis of lower extremity artery

159

1.84

2.44

2.8

3.4

—

Primary open-angle glaucoma

142

1761

0.77

2.43

3.5

3.7

—

Other and unspecified acute skin changes due to ultraviolet radiation

103

2.06

2.43

3.5

3.8

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

367

1.50

2.43

3.6

5.3

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

5.17

2.43

3.0

5.1

—

Haemophagocytic lymphohistiocytosis

6.78

2.42

5.0

3.6

—

Coronary artery bypass grafting

167

969

1.28

2.42

3.4

3.5

—

Vitamin deficiency, wide

174

1.79

2.42

4.4

3.9

—

Vitamin deficiency

174

1.79

2.42

4.4

3.9

—

Ulcerative colitis, NAS

497

1.45

2.42

3.1

3.9

—

Chronic tubulo-interstitial nephritis

145

1.88

2.42

2.4

3.3

—

Migraine without aura and triptan purchases

391

1.51

2.42

3.4

4.4

—

Disorders of eyelid in diseases classified elsewhere

110

2.02

2.41

4.0

3.7

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

6.57

2.40

3.8

4.4

—

Nail disorders

320

1.57

2.40

5.4

4.0

—

Drug-induced myopathy

4.33

2.40

2.7

3.3

—

Other disorders of pigmentation

182

1.77

2.40

4.0

3.4

—

Cervicobrachial syndrome

108

801

1.35

2.40

3.4

3.9

—

Congenital malformations of lung

6.52

2.40

4.0

3.3

—

Syphilis, including avohilmo

2.13

2.40

2.9

4.2

—

Syphilis

2.13

2.40

2.9

4.2

—

Primary Sclerosing Cholangitis, IBD and UDCA required

2.37

2.39

3.9

3.7

—

Congenital malformations of lung, including avohilmo

6.48

2.39

4.0

3.3

—

Malignant neoplasm of oesophagus, including Hilmo

153

1.85

2.39

4.6

4.1

—

Eating disorder

138

1.89

2.39

3.0

4.3

—

Herpesviral keratitis and keratoconjunctivitis

153

1.84

2.39

3.0

3.7

—

Varicose veins

368

2364

1.18

2.38

3.5

3.7

—

Cyst of kidney

337

1.55

2.38

3.9

3.8

—

Crushed, pushed or stepped on by crowd or human stampede

220

1.69

2.37

5.1

4.4

—

Dissocial personality disorder

2.64

2.37

4.0

3.7

—

Conductive and sensorineural hearing loss

493

2844

1.15

2.37

4.3

3.7

—

DVT of lower extremities

112

838

1.34

2.36

3.4

3.6

—

Psoriasis vulgaris

103

761

1.36

2.36

3.3

3.7

—

Adenomyosis (Endometriosis of uterus)

458

1.47

2.35

4.4

4.1

—

Disorders of vestibular function (Vertigo)

282

2293

1.20

2.34

4.2

3.7

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

275

1.60

2.33

4.1

—

Female genital prolapse

140

595

1.31

2.32

3.6

3.9

—

Sequelae of injuries of upper limb

363

1.52

2.32

3.8

4.0

—

Other shoulder lesions

339

1.54

2.32

3.6

3.9

—

Traumatic subdural haemorrhage

602

1.39

2.31

3.3

3.7

—

Intestinal helminthiases, other/unspecified, including avohilmo

4.82

2.30

2.7

3.3

—

Rheumatoid lung disease

3.60

2.30

3.7

4.0

—

Urethral stricture

269

1.61

2.29

3.1

3.7

—

Scleritis

2.98

2.29

3.0

4.6

—

Thrombotic microangiopathy

3.56

2.29

8.8

3.6

—

Vasomotor rhinitis (mode)

246

1.63

2.28

3.5

3.1

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

2.23

2.28

2.3

4.0

—

Benign neoplasm of other and unspecified endocrine glands

554

1.41

2.27

3.7

3.8

—

Thyrotoxicosis, other and/or unspecified

105

783

1.34

2.27

3.8

4.0

—

Alzheimer’s disease (Early onset), excluding more controls

163

0.35

2.27

3.3

3.9

—

Alcoholic liver disease

463

1.45

2.27

3.3

3.8

—

Benign neoplasm of major salivary glands

422

1.48

2.27

3.9

3.8

—

Tuberculosis of nervous system, including avohilmo

6.00

2.26

8.0

3.8

—

Tuberculosis of nervous system

6.00

2.26

8.0

3.8

—

Other follicular disorders

231

1.65

2.26

3.7

4.3

—

Duodenal ulcer

513

1.43

2.26

3.7

—

Dislocation, sprain and strain of joints and ligaments of thorax

113

1.96

2.26

2.7

3.8

—

Unspecified dementia

611

0.64

2.25

2.7

3.5

—

Effects of foreign body entering through natural orifice

128

985

1.30

2.23

3.5

3.9

—

Temporomandibular joint disorders, including avohilmo

194

1520

1.24

2.22

3.8

4.0

—

Varicella [chickenpox]

135

1.86

2.22

3.2

3.9

—

Acute generalized exanthematous pustulosis

157

1.80

2.22

8.4

3.6

—

Toxic effects of substances chiefly nonmedicinal as to source

400

1.48

2.20

3.5

4.1

—

Sequelae of cerebrovascular disease

244

1726

1.21

2.20

3.4

3.6

—

Tubulo-interstitial nephritis, not specified as acute or chronic

272

1.59

2.20

3.0

3.3

—

Malignant neoplasm of larynx, including Hilmo

2.15

2.20

7.8

4.5

—

Myeloproliferative diseases (CML excluded)

336

1.53

2.19

5.0

3.8

—

Erectile dysfunction

401

1.48

2.19

3.4

3.6

—

Essential (haemorrhagic) thrombocythaemia

158

1.79

2.18

6.6

4.2

—

Persons encountering health services in other circumstances

195

1567

1.23

2.17

3.8

—

Scar conditions and fibrosis of skin

129

1.87

2.17

3.5

3.6

—

Disorders of purine and pyrimidine metabolism

3.77

2.17

4.0

2.8

—

Corneal scars and opacities

101

2.00

2.16

3.3

4.2

—

Galactorrhea

3.73

2.16

3.1

4.3

—

Speech and linguistic disorders, excluding more controls

155

1.76

2.15

3.2

5.4

—

Cysts of oral region, not elsewhere classified

219

1.65

2.15

3.7

4.1

—

Lesion of radial nerve

144

1.82

2.15

3.4

3.7

—

Mixed disorders of conduct and emotions, excluding more controls

3.70

2.15

7.0

3.3

—

Hydronephrosis

485

1.43

2.15

3.7

3.5

—

Delirium, not induced by alcohol and other psychoactive substances

695

1.35

2.15

3.3

3.6

—

Injury of muscle and tendon at wrist and hand level

527

1.41

2.14

4.1

3.4

—

Other noninfective disorders of lymphatic vessels and lymph nodes

137

1.84

2.14

3.3

3.6

—

Other disorders starting during childhood or adolecense, excluding more controls

2.39

2.14

4.8

5.3

—

Lichen planus

553

1.40

2.13

3.5

3.9

—

Juvenile osteochondrosis

2.11

2.13

3.6

4.1

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

387

1.48

2.12

3.9

3.8

—

Other abnormalities of plasma proteins

2.24

2.12

7.0

3.9

—

Benign neoplasm: Skin of eyelid, including canthus

681

1.36

2.12

4.1

3.6

—

Respiratory and cardiovascular disorders specific to the perinatal period

3.70

2.12

8.4

9.6

—

Viral conjunctivitis

2.23

2.12

3.1

3.9

—

Typhoid and paratyphoid fevers, including avohilmo

3.27

2.11

7.4

4.2

—

Ulcer of oesophagus

307

1.54

2.11

3.4

3.6

—

Panniculitis affecting regions of neck and back

109

1.94

2.11

3.7

3.8

—

Conotruncal defects

3.23

2.10

5.9

3.2

—

D07AA Corticosteroids, weak (group I)

478

1.42

2.10

4.1

4.3

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

529

1.40

2.10

3.6

4.6

—

Immunodeficiency associated with other major defects

5.20

2.09

4.2

2.9

—

Hemiplegia

175

1.72

2.09

3.6

4.1

—

Disorders of the thyroid gland

535

3061

1.13

2.09

3.5

3.8

—

Spontaneous abortion

117

1017

0.77

2.09

4.5

4.0

—

Hydrocephalus

357

0.53

2.09

2.7

3.8

—

Fall involving bed

153

1.78

2.09

3.5

3.7

—

Thalassaemia

5.13

2.09

4.2

3.0

—

Gingival hyperplasia

131

1.85

2.08

3.7

3.8

—

Right ventricular outflow tract obstruction

5.06

2.08

6.6

2.0

—

Rheumatic fever incl heart disease

124

1.87

2.07

3.9

4.0

—

Typhoid and paratyphoid fevers

3.60

2.07

8.3

4.6

—

Personal history of certain other diseases

2.92

2.07

2.3

4.2

—

Fatigue fracture of vertebra

3.59

2.07

3.3

3.1

—

Acute alcohol intoxication, ICD10

107

813

1.32

2.07

3.9

—

Toxoplasmosis

3.58

2.07

3.0

4.1

—

Toxoplasmosis, including avohilmo

3.58

2.07

3.0

4.2

—

Primary open-angle glaucoma, strict

115

1482

0.77

2.06

3.5

3.7

—

Premenstrual syndrome

3.53

2.06

2.7

3.1

—

Benign neoplasm: Cerebral meninges

382

1.47

2.06

3.3

3.8

—

Unspecified transport accident

4.10

2.05

3.5

3.3

—

Diseases of the myoneural junction and muscle

583

1.38

2.05

3.1

3.7

—

Spondylolisthesis/Spondylolysis

711

1.34

2.05

4.3

3.8

—

IBD patients in KELA-register

107

815

1.32

2.04

3.7

3.9

—

Isolated proteinuria with specified morphological lesion

2.54

2.02

4.0

4.1

—

Acute drug-induced interstitial lung disorder

2.69

2.02

2.5

4.4

—

Contusion of toe(s) without damage to nail

2.24

2.01

4.4

3.9

—

Dissociative [conversion] disorders

2.06

2.01

3.6

3.8

—

Previous suicide attempt

2.85

2.01

3.4

3.7

—

Encephalitis

104

1.94

2.01

4.9

3.8

—

Postprocedural musculoskeletal disorders, not elsewhere classified

319

1.51

2.01

3.7

3.9

—

Phobic anxiety disorders

302

1.52

2.00

4.0

4.7

—

Acne

207

1.64

1.99

4.5

4.9

—

Type 1 diabetes

118

913

1.29

1.99

3.5

4.1

—

Sequelae of other and unspecified infectious and parasitic diseases

178

1.69

1.99

4.9

4.0

—

Asymptomatic human immunodeficiency virus [HIV] infection status

3.41

1.98

4.1

3.8

—

Toxic effect of other gases, fumes and vapours

3.40

1.98

3.4

4.0

—

Alzheimer’s disease, strict definition

128

1311

0.79

1.98

3.1

3.5

—

Medical abortion

281

1283

1.19

1.97

3.8

4.0

—

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

2.10

1.97

3.1

4.1

—

Dronedarone medication

112

1.89

1.97

3.4

4.4

—

Crystal arthropathies, rheuma endpoint

2.05

1.97

2.9

5.0

—

Malignant neoplasm of prostate, including Hilmo

173

823

1.24

1.96

3.3

3.9

—

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

3.90

1.96

6.8

3.6

—

Injury of blood vessels at hip and thigh level

4.69

1.96

2.8

2.7

—

Other encephalitis

1.96

3.6

—

Nonalcoholic fatty liver disease

370

1.47

1.95

3.1

4.0

—

Explicit fungal Sepsis

3.02

1.95

4.9

4.1

—

Explicit fungal Sepsis, including avohilmo

3.02

1.95

4.9

4.1

—

Enterobiasis, including avohilmo

2.58

1.94

2.9

4.0

—

Heartburn

387

1.45

1.94

5.2

4.0

—

Certolizumab pegol

2.47

1.93

3.7

3.4

—

Retinal vascular occlusion

615

1.36

1.93

3.5

—

Acne vulgaris

164

1.71

1.93

4.5

5.2

—

Other bursopathies

530

1.38

1.93

3.5

3.7

—

Post-traumatic stress disorder

142

1.76

1.92

3.8

4.4

—

Malignant neoplasm of larynx

2.27

1.92

8.8

5.1

—

Any dementia

212

1760

0.83

1.91

3.3

3.6

—

Other and unspecified mononeuropathies, also in other diseases

106

1.90

1.91

4.3

3.8

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

147

1.74

1.91

2.6

4.4

—

Other abnormal findings of blood chemistry

165

1.71

1.91

6.3

3.6

—

Bitten or struck by other mammals

364

1.46

1.90

4.4

4.1

—

Carbimazole or st.post thyroidectomy, condition for graves disease

103

790

1.31

1.90

4.1

4.0

—

Paralytic ileus

143

1.76

1.89

2.9

4.0

—

Other disorders of breast

414

1.43

1.89

3.3

4.0

—

Noninflammatory disorders of female genital tract

161

647

1.25

1.89

3.5

4.2

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

181

1.67

1.88

4.9

4.0

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

3.20

1.88

3.0

2.5

—

Other disorders of penis

406

1.43

1.88

5.2

3.6

—

Undefined dementia

601

0.67

1.88

2.7

3.5

—

Excessive, frequent and irregular menstruation

152

647

1.26

1.87

4.0

4.2

—

Internal derangement of knee

192

1570

1.21

1.87

3.6

3.9

—

Torticollis

2.67

1.87

3.0

4.9

—

Long labour

471

0.65

1.86

3.9

4.3

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

252

1.55

1.86

3.3

4.2

—

LSIL lesion of the cervix uteri

244

1.56

1.86

4.2

4.0

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

424

1.42

1.86

3.1

3.8

—

Use of galantamine

431

0.60

1.86

4.2

3.5

—

Unspecified nephritic syndrome

2.00

1.86

3.5

3.8

—

Behavioural disorders, excluding more controls

2.86

1.86

3.6

4.5

—

Systemic disorders of connective tissue in diseases classified elsewhere

3.63

1.85

4.3

3.2

—

Thyroiditis, ILD-related definition

366

1.45

1.85

4.0

3.9

—

Monoplegia

2.23

1.85

4.0

3.9

—

Glucagon-like peptide-1 (GLP-1) analogues

104

1339

0.78

1.85

3.2

3.9

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

104

1339

0.78

1.85

3.2

3.9

—

Seronegative rheumatoid arthritis

433

1.41

1.85

4.4

3.8

—

Cholecystitis

672

1.33

1.84

3.4

3.7

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

125

988

1.27

1.84

4.8

3.6

—

Other and unspecified syphilis, including avohilmo

4.27

1.84

2.8

3.6

—

Pediculosis, acariasis and other infestations, including avohilmo

552

1.36

1.83

4.3

4.1

—

malignant neoplasm of male genital organs

171

837

1.23

1.83

3.2

3.9

—

Postviral fatigue syndrome

4.21

1.83

3.8

3.0

—

Bipolar affective disorders

561

1.36

1.82

2.7

4.2

—

Drug-induced gout

3.13

1.82

4.0

4.6

—

Personal history of malignant neoplasm

294

1.50

1.82

3.4

3.7

—

Other retinal artery occlusion

101

1.90

1.81

3.3

4.1

—

Malignant neoplasm of endocrine gland, including Hilmo

254

1.54

1.81

3.9

4.2

—

Alcoholic cardiomyopathy

2.83

1.81

5.6

3.6

—

Injuries to the neck

110

858

1.28

1.80

4.1

3.9

—

Crohn's disease NAS

215

1.59

1.79

3.6

3.9

—

Embolic stroke with flimmer

116

1.82

1.79

2.6

3.3

—

Restless leg syndrome

572

1.35

1.79

4.6

3.8

—

Assault by sharp object

2.36

1.78

5.0

3.8

—

Benign neoplasm: salivary glands, exclude unknown (D119)

378

1.43

1.78

3.9

—

Malignant neoplasm of breast, HER-negative

682

1.31

1.78

3.8

—

Malignant neoplasm of breast, ER-negative, including Hilmo

713

1.30

1.78

3.7

3.9

—

Contact with sharp glass

109

1.84

1.77

5.9

3.8

—

Melanoma in situ

216

1.59

1.77

3.1

4.0

—

Benign neoplasm of ovary

625

1.33

1.76

3.5

3.6

—

Disturbances of smell and taste

154

1.70

1.76

3.0

4.4

—

Toxic effect of ethanol

124

1.78

1.76

4.8

3.8

—

Malignant neoplasm of digestive organs

220

1413

1.19

1.76

3.8

—

Other congenital malformations of urinary system

3.40

1.76

2.0

3.5

—

Other puerperal infections

124

1.78

1.75

3.0

4.2

—

Amputation of foot

117

1.81

1.75

3.9

3.5

—

Plantar fascial fibromatosis

346

1.45

1.75

3.0

3.9

—

Exophthalmic conditions

2.53

1.75

4.1

4.9

—

Carcinoma in situ of colon

132

1.76

1.74

3.9

3.3

—

Other infective spondylopathies

4.03

1.74

3.8

3.7

—

Reiter disease

2.73

1.74

4.4

3.7

—

Small plaque parapsoriasis

3.99

1.73

7.8

2.8

—

Nail dystrophy

2.97

1.73

3.7

4.4

—

Malignant melanoma

653

1.32

1.73

3.6

3.8

—

Polyarteritis nodosa

2.97

1.73

7.4

3.7

—

Systemic sclerosis,strict definition

2.71

1.73

2.6

3.7

—

Meralgia paraesthetica

125

1.77

1.72

3.0

3.8

—

Superficial injury of shoulder and upper arm

491

1.37

1.71

3.6

3.8

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

156

1.68

1.69

5.0

4.1

—

Glaucoma

284

2788

0.86

1.69

3.4

3.7

—

Other dialysis

111

1.82

1.69

4.0

3.7

—

Total colectomy operation

141

1.71

1.68

3.2

4.0

—

Total colectomy

141

1.71

1.68

3.2

4.0

—

Cluster headache, strict, including avohilmo

141

1.71

1.68

3.1

3.8

—

Crohn disease

450

1.38

1.68

3.5

4.1

—

Benign neoplasm: Parotid gland

333

1.45

1.67

4.0

—

Inflammatory bowel disease, strict (require KELA)

107

841

1.27

1.67

3.7

3.9

—

Use of levodopa decarbox-comt-inhibitor

161

0.43

1.67

2.4

4.0

—

Other and unspecified disorders of orbit

3.23

1.67

3.5

4.6

—

Use of disulfiram, acamprosate or naltrexone

300

1.47

1.67

4.2

4.0

—

Other symptoms and signs involving general sensations and perceptions

149

1.69

1.67

2.9

4.0

—

Other acquired deformities of musculoskeletal system and connective tissue

180

1.62

1.67

2.9

3.9

—

Other secondary coxarthrosis

134

1.73

1.66

4.0

3.5

—

Malignant neoplasm of oral cavity

134

1.73

1.66

3.0

4.2

—

Other and unspecified papulosquamous disorders

2.85

1.66

2.4

4.0

—

Other crystal arthropathies

1.91

1.66

2.9

4.7

—

Idiopathic urticaria

2.11

1.66

3.9

3.4

—

Diabetic nephropathy

762

1.29

1.66

2.8

3.5

—

Retinal vascular disorders

632

1.32

1.66

3.5

—

Other predominantly sexually transmitted diseases, not elsewhere classified

451

1.38

1.66

3.8

4.2

—

Other and unspecified acquired haemolytic anaemias

2.48

1.65

2.7

4.0

—

Lichen simplex chronicus and prurigo

252

1.52

1.65

3.5

3.8

—

Other otitis externa (chronic)

252

1.51

1.65

4.1

—

Other specified and unspecified retinal disorders

142

1.70

1.65

4.5

4.0

—

Recurrent dislocation and subluxation of joint

212

1.56

1.65

3.3

4.3

—

Benign neoplasm: Other and unspecified parts of mouth

127

1.74

1.64

5.9

3.6

—

Contusion of other and unspecified parts of foot

142

1.70

1.64

4.7

3.9

—

Perforation of tympanic membrane

393

1.40

1.64

3.8

—

Carcinoma in situ of skin of eyelid, including canthus

3.73

1.64

2.2

3.6

—

Actinomycosis

3.66

1.63

3.2

3.9

—

Toxic effect of organic solvents

3.66

1.63

3.6

2.9

—

Chondrocostal junction syndrome [Tietze]

135

1.71

1.63

3.6

3.8

—

Melanocytic naevi of lower limb, including hip

158

1.65

1.62

6.2

3.8

—

Other disorders of thyroid

2.17

1.62

3.6

3.8

—

Malignant neoplasm of testis, including Hilmo

2.16

1.61

3.3

3.7

—

Lesion of ulnar nerve

574

1.33

1.61

4.4

3.8

—

Primary biliary cholangitis, wide definition

1.88

1.61

7.5

4.0

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

635

1.31

1.61

3.8

3.9

—

Carcinoma in situ of skin of lip

3.11

1.60

3.0

3.5

—

Tibial collateral bursitis [Pellegrini-Stieda]

2.53

1.60

2.9

4.1

—

Viral encephalitis, not elsewhere classified/unspecified

1.97

1.60

3.2

4.1

—

Erectile dysfunction, exclusion

3.09

1.60

2.2

3.2

—

Benign neoplasm of other and unspecified intrathoracic organs

2.36

1.60

2.8

4.3

—

Hypersplenism

3.07

1.59

2.3

3.7

—

Organ-limited amyloidosis

3.06

1.59

2.7

3.1

—

Prolapse and hernia of ovary and fallopian tube

127

1.73

1.59

3.9

3.7

—

Erythema nodosum

106

1.81

1.59

3.4

3.6

—

Necrotizing fasciitis

3.06

1.59

6.0

2.3

—

Other inflammation of vagina/vulva

2.01

1.59

7.7

3.8

—

Injury of blood vessels at wrist and hand level

2.74

1.59

5.1

3.2

—

Abscess of tendon sheath

3.05

1.59

3.3

2.6

—

All dysplastic lesions of the cervix uteri, vagina or vulva

697

1.29

1.58

4.0

—

Abnormal findings on examination of urine, without diagnosis

167

1.63

1.58

4.3

—

Other and unspecified iridocyclitis

167

1.63

1.58

3.0

3.9

—

Mixed disorders of conduct and emotions

2.70

1.58

7.0

7.5

—

Ectropion of eyelid

199

1.57

3.7

3.2

—

Other noninflammatory disorders of uterus, except cervix

105

551

1.27

1.56

3.6

4.0

—

Cluster headache, wide,, including avohilmo

152

1.65

1.56

3.1

3.7

—

Disorders of breast

214

1600

1.18

1.56

3.3

4.0

—

Malignant neoplasm of urinary organs

414

1.38

1.56

3.0

3.9

—

Unspecified lump in breast

543

1.33

1.55

3.4

3.9

—

Fibrothorax

3.50

1.55

5.8

4.4

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

543

1.32

1.55

3.7

4.1

—

Disorders of synovium and tendon in diseases classified elsewhere

1.94

1.55

3.2

3.5

—

Gonarthrosis,primary

550

2993

1.11

1.54

3.3

3.8

—

Melanocytic naevi of other and unspecified parts of face

200

1.56

1.54

3.5

—

Pityriasis lichenoides chronica

3.41

1.53

2.6

3.1

—

Actinomycosis, including avohilmo

3.40

1.53

3.2

3.7

—

Unspecified misadventure during surgical and medical care

241

1.50

1.52

2.7

3.9

—

Glucosamine medication

297

2069

1.15

1.52

3.4

3.7

—

Complications of other internal prosthetic devices, implants and grafts

177

1.59

1.52

3.2

4.0

—

Other epidermal thickening

177

1.59

1.52

3.2

3.5

—

Other/unspecified mastoiditis and related conditions

2.92

1.52

3.0

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

2.19

1.52

3.3

3.9

—

Hypercalcemia

193

1.56

1.51

3.3

3.8

—

Cachexia

2.91

1.51

2.8

3.8

—

Diseases of inner ear

321

2699

1.14

1.51

4.1

3.8

—

Nontoxic multinodular goitre

107

854

1.26

1.51

3.5

3.8

—

Alzheimer’s disease (Late onset)

123

1244

0.81

1.51

3.1

3.6

—

Dysplastic lesion of unknown severity of the cervix uteri

2.88

1.51

3.0

3.7

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

383

1.39

1.51

3.7

4.0

—

Paranoid personality disorder

2.09

1.50

5.2

4.3

—

Overjet

0.00

1.49

0.0

6.9

—

Procedures for purposes other than remedying health state

1.96

1.49

6.4

4.0

—

Male infertility

116

1.73

1.48

8.2

3.9

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

719

0.79

1.48

3.8

4.2

—

Artificial joint operation, meniscal resection

547

3166

1.11

1.48

3.4

3.8

—

Other papulosquamous disorders

2.25

1.47

3.0

3.5

—

Endometriosis

134

634

1.23

1.47

3.7

4.1

—

Other injuries of upper limb, level unspecified

2.25

1.47

3.4

4.2

—

Ulcerative colitis (strict definition, require KELA)

583

1.31

1.47

3.8

4.0

—

Other and unspecified medical devices associated with adverse incidents

2.56

1.46

3.6

4.4

—

Postpartum care and examination

137

0.50

1.46

4.1

4.5

—

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

2.40

1.46

3.6

4.2

—

Combined immunodeficiencies

2.40

1.46

5.3

4.9

—

Carcinoma in situ of penis

3.29

1.46

8.8

3.8

—

Dependence on enabling machines and devices, not elsewhere classified

2.24

1.46

4.3

3.8

—

Hodgkin lymphoma, hilmo

102

1.78

1.45

3.5

4.0

—

Other and unspecified follicular disorders

140

1.65

1.45

3.9

4.0

—

Contact with sharp object, undetermined intent

1.89

1.45

4.3

3.9

—

Open wound of thorax

2.14

1.45

2.8

4.0

—

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

3.20

1.45

2.8

3.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

541

1.32

1.45

3.3

3.9

—

LSIL lesion of the cervix uteri, vagina or vulva

352

1.39

1.44

4.2

4.0

—

Melanoma in situ of other and unspecified parts of face

2.00

1.44

3.8

4.3

—

Urethritis and urethral syndrome

1.93

1.44

3.2

3.8

—

Postpartum haemorrhage

470

0.70

1.44

3.7

4.4

—

Malignant neoplasm of small intestine, including Hilmo

125

1.69

1.44

3.0

4.1

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

2.05

1.44

3.0

4.1

—

Other forms of systemic lupus erythematosus

2.76

1.44

3.0

4.3

—

Injury of muscle and tendon at shoulder and upper arm level

208

1781

1.17

1.44

3.6

3.7

—

Blepharospasm

2.34

1.44

7.1

3.8

—

Lesion of sciatic nerve

201

0.49

1.44

3.5

3.9

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

2.33

1.43

5.0

4.7

—

Other acute viral hepatitis

2.33

1.43

2.1

4.4

—

Toxic effect of other and unspecified substances

2.33

1.43

3.6

4.1

—

Colectomy operation

789

1.26

1.43

3.8

3.7

—

Chronic ulcer of skin, not elsewhere classified

311

1.42

1.43

3.4

3.8

—

Malignant neoplasm of prostate

165

815

1.20

1.43

3.1

3.8

—

Salpingitis and oophoritis

577

1.30

1.43

4.1

3.8

—

Neuralgia and neuritis, unspecified

196

1.54

1.43

4.9

4.2

—

Emotional disorders starting during childhood or adolecense, excluding more controls

2.30

1.42

4.2

4.7

—

Superficial injuries involving multiple body regions

1.83

1.42

5.8

3.8

—

Menorrhagia

139

636

1.22

1.41

3.9

4.1

—

Lack of expected normal physiological development

3.13

1.41

2.8

12.5

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.86

1.41

4.4

5.9

—

Familial hypercholesterolemia

702

1.27

1.41

3.6

—

Other injuries of lower limb, level unspecified

2.28

1.41

3.7

—

Peroneal tendinitis

2.19

1.40

3.3

3.9

—

Malignant neoplasm of kidney, except renal pelvis

380

1.37

1.40

3.0

3.9

—

Excessive attrition of teeth

295

2568

1.14

1.40

4.2

3.9

—

Injuries involving multiple body regions

126

1.68

1.40

7.4

3.6

—

Conduct disorder

2.26

1.40

3.6

4.3

—

Other and unspecified disorders of pigmentation

2.45

1.40

3.6

3.9

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

596

1.29

1.40

3.6

4.1

—

Other injuries of spine and trunk, level unspecified

2.44

1.40

2.6

3.7

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

2.43

1.39

3.1

3.5

—

Acute nasopharyngitis (common cold)

369

1.37

1.39

3.1

3.5

—

Acute posthaemorrhagic anaemia

142

1.63

1.38

3.8

3.9

—

Sensorineural hearing loss

460

2763

1.11

1.38

4.2

3.7

—

Enteropathic arthropathies

1.95

1.38

4.4

3.5

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

484

1.33

1.38

3.8

4.0

—

Contact with machinery

481

0.68

1.38

4.1

3.8

—

Benign neoplasm: Skin, unspecified

150

1.61

1.38

3.6

3.8

—

Moderate visual impairment, binocular

120

0.41

1.37

6.2

3.6

—

Benign neoplasm: Liver/bile ducts

1.81

1.37

2.7

4.0

—

Malignant neoplasm of nasal cavity and sinuses

2.65

1.37

3.7

3.0

—

Assault by other specified means

2.63

1.37

2.7

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

3.02

1.37

5.0

3.4

—

Congenital malformations and deformations of the musculoskeletal system

213

1.50

1.37

3.1

4.3

—

Injury of blood vessels at neck level

3.00

1.37

3.4

3.0

—

Contact with blunt object, undetermined intent

2.98

1.36

4.4

2.8

—

2.95

1.36

9.0

3.4

—

Other disorders of glucose regulation and pancreatic internal secretion

323

1.40

1.35

3.5

3.8

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

350

0.68

1.35

3.6

3.7

—

Embolic stroke

215

1.49

1.35

2.8

3.6

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

127

1048

1.21

1.35

3.1

3.9

—

Benign neoplasm: Liver

1.88

1.35

2.8

4.1

—

Cerebral palsy

0.00

1.34

0.0

2.8

—

Use of entacapone

0.00

1.34

0.0

4.4

—

Other abnormal uterine and vaginal bleeding

102

588

1.25

1.34

3.8

4.0

—

Alzheimer’s disease (undefined)

0.00

1.34

0.0

3.7

—

Primary biliary cholangitis (PBC)

1.79

1.33

4.3

4.0

—

Benign mammary dysplasia

505

1.31

1.33

3.6

—

Cervical polyps

321

0.62

1.33

3.5

4.2

—

Presbycusis

788

1.24

1.32

3.5

3.4

—

Hyperplasia of prostate

234

1141

1.16

1.32

3.7

3.6

—

Outcome of delivery

176

1.43

1.32

4.0

4.3

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

567

1.29

1.32

3.8

4.0

—

Malignant neoplasm of other connective and soft tissue

1.75

1.31

4.9

4.5

—

Enteritis due to Yersinia enterocolitica

2.54

1.31

6.5

3.8

—

Open wound of shoulder and upper arm

1.86

1.30

6.1

4.1

—

Disorder of pancreatic internal secretion, other and/or unspecified

2.39

1.30

4.9

4.3

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

1.85

1.30

2.7

3.5

—

Melanoma in situ of scalp and neck

2.87

1.30

2.6

4.0

—

Other diseases of spinal cord

106

1.71

1.30

3.8

4.2

—

Other disorders starting during childhood or adolescence

1.90

1.29

4.8

6.2

—

Marginal zone B-cell lymphoma, including Hilmo

1.90

1.29

2.6

5.0

—

Testicular dysfunction, other/unspecified

2.82

1.29

5.4

5.0

—

Benign neoplasm: Rectosigmoid junction

169

1.55

1.29

4.2

3.8

—

Impaction of intestines

2.81

1.29

6.2

3.4

—

Thyrotoxicosis with toxic multinodular goitre

251

1.44

1.28

3.2

3.7

—

Hallux rigidus

605

1.28

3.6

3.8

—

Social phobias

169

1.54

1.28

4.3

4.6

—

Collapsed vertebra, not elsewhere classified

2.32

1.28

4.6

4.1

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.30

1.27

9.0

3.7

—

Sacrococcygeal disorders, not elsewhere classified

1.79

1.27

2.9

3.5

—

Malignant neoplasm of testis

2.06

1.27

3.6

3.9

—

Postprocedural disorders of digestive system, not elsewhere classified

130

1.62

1.27

4.1

3.8

—

Exclusion endpoint for clefts

2.05

1.26

5.3

2.9

—

Other/unspecified disorders of vestibular function

178

1.53

1.26

3.1

3.7

—

Isolated proteinuria

107

1.69

1.26

5.1

3.9

—

Pustulosis palmaris et plantaris

146

1.58

1.26

3.3

3.5

—

Mixed hyperlipidaemia

162

1.55

1.26

3.5

3.9

—

Spontaneous rupture of synovium and tendon

328

1.38

1.26

3.0

3.9

—

Other sexually transmitted chlamydial diseases, including avohilmo

178

1.52

1.25

5.0

—

Infarction of spleen

2.26

1.25

2.4

4.1

—

Fibrosis of liver

2.26

1.25

10.1

4.2

—

Infective bursitis

115

1.66

1.25

4.3

5.3

—

Presence of other functional implants

362

2221

1.12

1.25

3.6

3.8

—

Cholecystectomy

403

3091

1.11

1.23

3.4

3.8

—

Deficiency of other B group vitamins

1.78

1.23

3.6

3.9

—

Other and unspecified rosacea

321

1.37

1.23

3.2

3.9

—

Myopia

381

1.34

1.23

3.0

4.4

—

Irregular menses

173

1110

1.17

1.23

4.7

3.9

—

All dysplastic lesions of the cervix uteri

573

1.27

1.22

4.1

4.0

—

Unspecified parasitic disease

2.19

1.22

5.0

3.4

—

Unspecified parasitic disease, including avohilmo

2.19

1.22

5.0

3.4

—

Certain conditions originating in the perinatal period

123

1.59

1.22

8.0

4.9

—

Whooping cough, including avohilmo

2.17

1.21

4.8

4.1

—

Rheumatic valve diseases

1.73

1.21

3.8

3.9

—

Desensitization to allergens

116

1.64

1.21

4.4

3.6

—

Congenital malformations of the urinary system

180

1.51

1.21

3.3

4.2

—

Necrosis of pulp, including avohilmo

280

2455

1.13

1.20

3.9

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

142

0.49

1.20

3.3

4.5

—

Carcinoma in situ of other and unspecified sites

205

1.47

1.20

4.3

3.9

—

Contraceptive management

118

991

0.83

1.19

4.7

4.0

—

Varicose veins of other sites

275

0.62

1.19

4.3

4.1

—

Other disorders of peripheral nervous system

2.34

1.19

3.7

3.0

—

Atlantoaxial subluxation

2.34

1.19

2.7

4.5

—

Other disorders of nervous system

289

1.39

1.19

3.0

3.8

—

2.33

1.19

3.7

4.2

—

Other osteochondrodysplasias

2.33

1.19

4.0

3.7

—

Primary adrenocortical insufficiency

2.13

1.19

5.1

3.8

—

Noise effects on inner ear

168

0.53

1.19

3.1

4.1

—

Benign neoplasm: Descending colon

332

1.36

1.19

2.8

3.8

—

Malignant neoplasm of oropharynx

1.89

1.18

5.4

5.3

—

Behavioural disorders

2.11

1.18

3.6

4.3

—

Nonspecific lymphadenitis

181

1.50

1.18

3.9

—

Peritonsillar abscess

595

1.26

1.17

3.5

3.9

—

Benign neoplasm: Appendix

2.02

1.17

5.0

4.0

—

Benign neoplasm: Oesophagus

2.02

1.17

4.0

—

Dislocation, sprain and strain of joints and ligaments of knee

279

2241

1.13

1.17

3.8

4.1

—

Other protozoal intestinal diseases

2.02

1.17

5.4

3.9

—

Pre-eclampsia or eclampsia

613

0.75

1.16

4.0

—

Secondary parkinsonism

129

0.46

1.16

2.5

3.7

—

Vitamin B12 deficiency anaemia

481

1.29

1.16

3.5

3.6

—

Lichen planus, including avohilmo

102

839

1.22

1.16

4.9

3.5

—

Toxic colitis

2.56

1.16

2.8

3.0

—

Prolonged pregnancy

244

0.63

1.16

6.9

4.6

—

Combinations of oral blood glucose lowering drugs

120

1430

0.84

1.16

3.2

3.8

—

Speech disturbances, not elsewhere classified

394

1.32

1.16

2.9

3.6

—

Malignant neoplasm of oropharynx, including Hilmo

2.54

1.16

7.0

4.1

—

Malignant neoplasm of floor of mouth

2.54

1.16

3.2

3.8

—

Malignant neoplasm of corpus uteri

309

0.65

1.16

3.1

3.6

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.07

1.15

5.0

3.9

—

Unspecified mental disorder

181

1566

1.16

1.15

3.4

3.9

—

Hyperkinetic disorders

234

1.42

1.15

2.8

5.3

—

Benign paroxysmal vertigo

162

1391

1.17

1.15

4.4

3.7

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

150

1.54

1.14

3.0

3.9

—

Alzheimer’s disease (undefined), excluding more controls

0.00

1.14

0.0

3.8

—

Convergence insufficiency and excess

0.00

1.14

0.0

3.9

—

Algoneurodystrophy

1.69

1.14

3.1

3.7

—

Unspecified event, undetermined intent

1.76

1.13

3.7

4.3

—

Unspecified threat to breathing

2.36

1.13

3.7

3.8

—

Brain meningioma

175

1.49

1.13

3.3

4.1

—

severe traumatic brain injury, does not include concussion

135

1144

1.18

1.12

3.2

3.5

—

Protein-energy malnutrition of moderate and mild degree

2.02

1.12

2.8

4.7

—

Serous carcinoma of ovary, including Hilmo

114

0.44

1.12

3.4

3.7

—

Cramp and spasm

167

1.50

1.12

4.6

3.6

—

Dystonia

200

1.46

1.12

5.7

4.1

—

Maternal care for known or suspected abnormality of pelvic organs

405

0.75

1.12

3.1

4.3

—

Acute appendicitis, no complications

259

2287

1.13

1.12

3.5

4.0

—

Organic, including symptomatic, mental disorders

286

2250

0.89

1.12

3.5

3.6

—

Carcinoma in situ, bladder

192

1.47

1.12

4.0

—

Other noninflammatory disorders of vagina

225

1.43

1.12

3.7

4.1

—

Diabetic maculopathy, excluding more controls

436

0.71

1.12

3.6

3.9

—

Dermatopolymyositis (FG)

1.98

1.12

3.9

3.6

—

Malnutrition

1.72

1.11

3.5

4.1

—

Ankylosing spondylitis, ICD10

310

1.36

1.11

4.1

4.0

—

Chronic suppurative otitis media, including avohilmo

293

1.37

1.11

4.4

4.2

—

Diseases of peritoneum

441

1.30

1.10

3.5

3.9

—

Cholangitis (primary sclerosing, PSC)

268

1.39

1.10

3.6

4.0

—

Ulcerative rectosigmoiditis

285

1.37

1.10

3.7

4.0

—

Speech and linguistic disorders

200

1.44

1.10

3.2

4.6

—

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

2.42

1.10

4.0

3.2

—

Mild or no visual impairment, binocular

2.42

1.09

5.6

4.1

—

Unspecified contracted kidney

2.41

1.09

3.4

3.5

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

772

1.22

1.09

4.4

4.2

—

Malignant neoplasm of oropharynx, including Hilmo

1.74

1.09

5.6

5.0

—

Other spirochaetal diseases, including avohilmo

176

1528

1.15

1.09

3.6

3.8

—

Injury of nerves at forearm level

1.97

1.09

3.4

3.1

—

Spasmodic torticollis

112

1.62

1.09

4.2

3.6

—

Polymyositis

2.21

1.08

4.1

3.9

—

Other sexually transmitted chlamydial diseases

112

1.61

1.08

4.7

4.3

—

Malignant neoplasm of bone and articular cartilage

2.21

1.08

3.7

4.8

—

Thyroiditis

235

1.41

1.08

4.7

3.6

—

Arthropathy in Crohn disease

2.21

1.08

5.1

3.6

—

Presence of other devices

111

1301

0.84

1.08

3.5

3.7

—

Oral lichen planus, including avohilmo , including avohilmo

269

1.38

1.08

4.2

4.0

—

Carcinoma in situ of rectum

1.88

1.08

3.5

3.2

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

469

1.28

1.08

4.2

—

Pure hyperglyceridaemia

1.70

1.08

4.5

—

Lyme disease

172

1493

1.15

1.07

3.7

3.8

—

Lyme disease, including avohilmo

172

1493

1.15

1.07

3.7

3.8

—

Pustular psoriasis

169

1.49

1.07

3.2

3.6

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

281

2125

0.89

1.07

4.0

4.1

—

Triptan medication for migraine, single purchase ok

281

2125

0.89

1.07

4.0

4.1

—

Other noninflammatory disorders of vulva and perineum

278

1.37

1.07

3.7

4.3

—

Schizophrenia or delusion

138

1178

1.17

1.07

3.5

3.9

—

Hypermetropia

244

1.40

1.07

3.8

4.4

—

Open wound of hip and thigh

1.66

1.07

3.4

3.9

—

Ill-defined and unknown causes of mortality

512

0.74

1.06

3.9

3.6

—

Benign neoplasm: Endocrine pancreas

2.16

1.06

3.0

4.0

—

Intentional self-harm by unspecified means

2.14

1.06

4.6

3.9

—

False labour

397

0.76

1.05

3.3

4.3

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

177

1131

1.15

1.05

4.1

3.9

—

Other spirochaetal diseases

173

1505

1.15

1.05

3.7

3.8

—

Cerebral aneurysm, nonruptured

331

1.33

1.05

4.8

3.9

—

Orchitis and epididymitis

392

1.30

1.05

3.6

3.5

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

286

1.36

1.05

3.6

4.4

—

Other disorders of optic [2nd] nerve and visual pathways

237

1.40

1.04

5.3

4.0

—

Schizophrenia, schizotypal and delusional disorders

138

1181

1.17

1.04

3.5

3.9

—

Monocytic leukaemia

2.32

1.04

2.6

4.4

—

Congenital malformations of the urinary system, including avohilmo

195

1.44

1.04

3.3

4.2

—

Acquired stenosis of external ear canal

1.98

1.04

3.4

3.6

—

Spondylopathies in diseases classified elsewhere

1.97

1.04

2.6

3.7

—

Disorders of psychological development

243

1.38

1.04

5.2

—

Seronegative juvenile rheumatoid arthritis

2.28

1.03

2.6

3.3

—

Malignant neoplasm of stomach, including Hilmo

246

1.39

1.03

3.9

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

1.64

1.03

3.0

3.7

—

Dissection of aorta

138

1.53

1.03

3.1

3.7

—

Acute nephritic syndrome

1.75

1.03

5.3

4.0

—

Retinal breaks without detachment

706

1.22

1.03

3.5

3.6

—

Benign neoplasm: Pancreas

130

1.55

1.03

2.6

3.9

—

Chorioretinal inflammation

106

1.61

1.03

2.6

3.9

—

Hypothyroidism, strict autoimmune

366

2181

1.10

1.03

3.4

3.8

—

Brain meningioma, including Hilmo

179

1.46

1.03

3.3

4.1

—

Viral conjunctivitis, including avohilmo

114

1.59

1.02

3.1

3.9

—

Malignant neoplasm of colon, including Hilmo

821

1.20

1.02

4.0

3.8

—

Calcific tendinitis of shoulder

196

1.43

1.02

3.1

4.3

—

Malignant neoplasm of other and unspecified parts of tongue

1.90

1.02

3.3

3.8

—

Bursitis of shoulder

1.70

1.01

3.4

—

Radial styloid tenosynovitis [de Quervain]

163

1.48

1.01

4.1

3.3

—

Other and unspecified nerve root and plexus disorders, also in other diseases

100

835

1.20

1.01

3.4

3.8

—

Amyloidosis

1.66

1.01

3.3

3.5

—

Acute epiglottitis

1.89

1.00

3.6

3.5

—

Testicular dysfunction

147

1.50

1.00

3.9

4.7

—

Disorders of magnesium metabolism

2.02

1.00

2.0

3.4

—

Emotional disorders and disorders of social functioning with onset specific to childhood

1.89

1.00

4.4

6.5

—

Other and unspecified injuries of ankle and foot

107

1.59

0.99

6.7

3.9

—

Chronic suppurative otitis media

248

1.37

0.99

4.3

3.8

—

Disorders of optic nerve and visual pathways

317

1.33

0.99

4.8

3.9

—

Secondary parkinsonism+Parkinsonism in other disease

132

0.53

0.99

2.7

3.6

—

Chronic iridocyclitis

164

1.47

0.99

3.6

3.9

—

Colorectal cancer, including Hilmo

143

1149

1.16

0.99

3.7

—

Disturbance of activity and attention

217

1.40

0.99

2.8

5.5

—

Benign lipomatous neoplasm

152

1318

1.15

0.99

3.8

3.7

—

Superficial injury of neck

1.85

0.98

5.0

3.8

—

Thiamine deficiency

0.00

0.98

0.0

3.3

—

Macular cyst

148

1.50

0.98

4.2

3.6

—

Melanocytic naevi of scalp and neck

1.68

0.98

2.9

4.0

—

Other acute disseminated demyelination

0.00

0.98

0.0

2.7

—

Coarctation of the aorta

0.00

0.98

0.0

2.8

—

Hydrocele

575

1.24

0.98

3.1

3.5

—

Spirochaetal infections, other/unspecified, including avohilmo

172

1506

1.14

0.97

3.7

3.8

—

Foreign body in alimentary tract

198

1.42

0.97

3.5

4.1

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mycobacterium sp identified in Sputum by Organism specific culture

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS